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ASSOCIATION OF QUALITY AND QUANTITY OF FAT INTAKE WITH LIPOPROTEIN 
SUBCLASSES 
 
Several studies have shown significant associations between intake of various fatty acids and 
lipoproteins. However, little is known about the associations between the consumption of 
different dietary fatty acids and lipoprotein subclasses. The aim of this Master’s thesis was to 
investigate the cross-sectional association of dietary fat intake with subclasses of lipoproteins in 
elderly women. 
Altogether 554 women (aged≥ 65 years), who were part of population based OSTPRE cohort 
study filled out three days’ food record and had blood sampling. The food records were used to 
calculate intake of dietary fat including polyunsaturated fatty acids, monounsaturated fatty acids, 
saturated fatty acids (SFA), total fat, palmitic acid, stearic acid, linoleic acid, linolenic acid, 
arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid. Lipoprotein subclasses were 
determined by nuclear magnetic resonance spectroscopy. Participants answered to the questions 
about lifestyle and health information such as intake of dietary supplements and medications, 
physical activity, disease status, menopause time, smoking and alcohol intake through self-
administrated postal questionnaire at baseline. Data have been collected between February 2003 
and May 2004 from women who were born in 1932-1941. 
Data were analyzed by IBM SPSS statistics software (version 21). Pearson and Spearman 
correlation coefficients were used to investigate the correlations between dietary fat and 
lipoprotein subclasses. The ANCOVA test was conducted to find the relation between tertiles of 
SFA (E%) and lipoprotein subclasses with adjustment for physical activity, BMI, age, smoking 
and intake of lipid lowering drugs. The pairwise differences were checked by Bonferroni test.  
Most of the significant correlations were observed between SFA and lipoprotein subclasses. For 
example, SFA positively associated with higher concentrations small, medium and large LDL 
particles. After adjustment for covariates, the intake of SFA significantly associated with lower 
size of LDL particles (p=0.04) and lower amount of TG in small VLDL (p= 0.046). Furthermore, 
higher intake of SFA tended to be in significant relation with higher amount of phospholipid in 
small LDL (p=0.06).   
 
Higher dietary intake of SFA associated with lower size of LDL which might increase the risk of 
heart diseases. Further studies of SFA intake and lipoprotein subclasses are needed to confirm 
the result and to clarify the clinical meanings of these associations.  
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1. INTRODUCTION 
Lipid profile of plasma contains the broad spectrum of lipid molecules that can be divided into 
six categories, including glycerolipids, fatty acyls, glycerophospholipids, sterols, sphingolipids 
and prenols (Quehenberger et al. 2010). Plasma lipid profile is an important factor that exerts a 
powerful effect on various diseases, especially cardiovascular diseases (CVD). This profile 
depends on the synthesis of lipid in the body and intake of fat from diet (Kwiterovich 2009). 
Therefore, the quality and quantity of fat intake are very important. In addition, since lipid 
cannot circulate throughout the body individually and needs lipoproteins as carriers, the 
concentration of lipoproteins in plasma is a momentous factor. There are five different types of 
lipoproteins with various functions, densities, sizes and compositions and each can be separated 
into diverse subclasses using methods like nuclear magnetic resonance spectroscopy (Ala-
Korpela 2008, Ross et al. 2012). Considering the fact that, the concentration of lipoproteins can 
be improved by the help of diet as an environmental factor, many researches have provided 
valuable knowledge about the effect of diet on the quantity of lipoproteins in circulation. 
However, further studies have revealed that the distributions of different subclasses of 
lipoproteins are extremely important in predicting the future diseases (Krauss 2001, Felder et al. 
2008, Gerber & Bernis 2012, Kim et al. 2012, Filippatos et al. 2013, Pirillo et al. 2013). In this 
research, the aim is to examine the association between quality and quantity of fat intake and 
serum lipoprotein subclasses.  
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2. LITERATURE REVIEW 
2.1 Lipoprotein 
Triglycerides (TG), phospholipids, cholesterols and other lipids need special molecules to 
circulate in the blood. The chemical structure of lipoproteins allows them to transport the lipids 
throughout the blood stream and body as a whole. These particles are made from lipids and 
proteins (Brody 1999). As shown in Picture 1, lipoprotein is a spherical molecule with polar 
lipids (phospholipids and cholesterol) in the surface and hydrophobic lipids (cholesterol esters 
and TG) in the core. Furthermore, the protein parts of this molecule named apolipoproteins or 
apoproteins are attached to the surface of particles. Lipoproteins are more soluble and detectable 
for enzyme and receptors by the help of their proteins (Warrell et al. 2003, Ross et al. 2012). 
 
There are five types of lipoproteins, including chylomicrons, very low density lipoprotein 
(VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL), and high density 
lipoprotein (HDL). These particles, which are made in the small intestine and liver, vary based 
on functions, densities, sizes and compositions. In addition, they are affected by diet and have 
different effect on health (Brody 1999, Moredich et al. 2005, Ross et al. 2012). 
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2.2 Lipoprotein Subclasses 
Earlier researchers were exploring the relation between plasma concentration of lipoproteins and 
diet, these days new analysis methods that define various subclasses of lipoproteins provide the 
opportunity to study more thoroughly lipoprotein metabolism. Subclasses of lipoproteins can be 
differentiated by their density and size, and they are measured by diverse methods such as 
nuclear magnetic resonance spectroscopy (NMR), vertical rotor ultracentrifugation, and gradient 
gel electrophoresis (Moredich et al. 2005, Schaefer et al. 2009, Gerber & Berneis 2012).  
 
2.2.1 Lipoprotein Subclasses Defined By NMR Method 
NMR is a method which is based on the principle that each subclass of lipoproteins has a unique 
signal in a magnetic field (Felder et al. 2008), and it provides the opportunity of measuring broad 
spectrum of metabolites (more than 100 metabolites by a single analytical method) (Kettunen et 
al. 2012). Although multi- metabolic characteristics of serum lead to creation of overlapping 
signals, the content of metabolites and concentration of them can be measured by empirical 
setting and advanced computational methods (Inouye et al. 2010). 
 
 
Picture 1: lipoprotein, source: (Warrell et al. 2003) 
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In overall, numerous subclasses of lipoproteins can be determined by NMR method (Ala-
Korpela 2008). For example, in a study involving prediabetic participants, more than 30 
variables related to lipoprotein subclasses were defined using NMR. Lipoprotein particles were 
classified into nine subclasses, including three subclasses of VLDL, IDL, two subclasses of LDL 
and three subclasses of HDL (Festa et al. 2005).  
 
2.2.2 Lipoprotein Subclasses Defined By Other Methods than NMR  
Besides the NMR method, other methods can be used to classify the lipoproteins. Two 
subclasses of LDL can be determined by non-denaturing gradient gel electrophoresis and 
analytic ultracentrifugation. These two methods show that the most abundant form of LDL 
subclass is denser and smaller one called LDL type B. On the contrary, there is LDL type A 
which is bigger, less dense and less pathogenic than LDL type B (Krauss 2001). In addition, 
several subclasses of HDL can be defined by mentioned methods, for example; HDL is classified 
into two categories using ultracentrifugation method providing HDL2 and HDL3. HDL3 is 
smaller and denser than HDL2. These subclasses of HDL can have further division based on 
their size (HDL2b, HDL2a, HDL3a, HDL3b and HDL3c) by non-denaturing gradient gel 
electrophoresis method (Pirillo et al. 2013). 
 
2.3 Factors Affecting Subclasses of Lipoproteins 
The concentration of lipoprotein subclasses in our body is affected by genetic factors (Krauss 
2001, Shah 2006, Kettunen et al. 2012). It is estimated that 50- 70% of the variation in the 
concentration of different lipoprotein particles is heritable (Kettunen et al. 2012). On the other 
hand, non-genetic factors such as diet, age, menopausal state and obesity are related to the 
concentration of lipoprotein subpopulation in plasma. Moreover, numerous diseases significantly 
correlate with the distribution of lipoprotein subclasses in the blood stream (Williams et al. 1993, 
Krauss 2001, Freedman et al. 2004, Mäntyselkä et al. 2012). 
 
2.3.1 Demographic Characteristics  
Concentrations of small LDL and small HDL were higher in adult men as compared to the 
younger boys using nondenaturing gradient gel electrophoresis (Williams et al. 1993, Krauss 
2001). Using NMR method, it was shown that the concentration of large HDL had a negative 
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correlation with age only in women, but not in men (Freedman et al. 2004). In addition, the 
concentrations of small and medium HDL increased with age in women. That led to lower 
average size of HDL in older women than in younger women. Furthermore, LDL size had weak 
negative correlation with age in both genders (Freedman et al. 2004).   
 
Regarding gender, men usually have more atherogenic lipoprotein subclasses’ profile than 
women (Freedman et al. 2004). They had smaller size of LDL and smaller size of HDL. In 
addition, men had higher concentration of VLDL and larger mean size of VLDL than women. 
The larger mean size of VLDL in men was due to having higher concentrations of large and 
medium VLDL as compared to women (Freedman et al. 2004). Furthermore, postmenopausal 
women had higher concentrations of small LDL and small HDL than premenopausal women 
(Williams et al. 1993, Krauss 2001).   
 
2.3.2 Plasma Concentration of Lipids, Lipoproteins and Apolipoproteins 
The lipoproteins and lipid profile of plasma associate with each other. High percentage of LDL 
type B was usually seen in patients with TG level higher than 1.58-1.81 mmol/l. Patients who 
had a TG level lower than 1.13-1.24 mmol/l often did not have high prevalence of small LDL 
(Krauss 2001, Gerber & Berneis 2012). In addition, the size of LDL negatively correlated with 
the concentration of HDL in plasma (Shah 2006). Concentrations of LDL, TG, and total 
cholesterol had negative correlations with HDL particle size, as well. Moreover, Tian and Fu 
(2010) reported that even though the impact of diverse hyperlipidemia on the distribution of 
HDL subclasses was mildly different, high concentration of small HDL and low concentration of 
large HDL were usually seen in hyperlipidemic subjects.  
 
2.3.3 Adiponectin 
Adiponectin is a protein that is secreted from adipocytes into the blood stream and have strong 
correlation with insulin sensitivity (Shin & Kim 2011, Vanhala et al. 2011). It was found that 
adiponectin concentration had positive correlations with LDL particle size and concentration of 
HDL2 (Shin & Kim 2011) reflecting the more favorable profile of lipoprotein particles (Vanhala 
et al. 2011). In addition, it had negative correlation with the concentration of HDL3 in plasma. It 
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should be mentioned that the relation of LDL particle size and adiponectin was not significant 
after adjusting for TG levels (Shin & Kim 2011).  
 
2.3.4 Obesity 
Obesity is another factor, which is related to lipid profile. It has been reported that the 
concentrations of HDL and HDL2 increased by weight loss (Moriyama et al. 2014). A cohort 
study with 6.5 years follow up showed that even mild weight loss shifted the lipoprotein profile 
to a more favorable one (Mäntyselkä et al. 2012). The higher proportion of larger HDL was seen 
in participants who lost weight. In addition, the concentrations of small, medium and large LDL 
besides the mean size of VLDL decreased in this group (Mäntyselkä et al. 2012). 
 
2.3.5 Lipid Lowering Drugs  
Drugs modulating cholesterol and fatty acids have impacts on the composition of lipoprotein 
subclasses. Statins most often are used to decrease the concentration of cholesterol in circulation 
(Rizzo & Berneis 2006). 
 
The effect of atorvastatin on subclasses of lipoproteins defined by the NMR method was 
analyzed in two studies (Soedamah et al. 2003, Ikewaki et al. 2009). While Ikewaki and his 
colleagues reported that atorvastatin decreased the concentrations of all LDL subclasses with 
higher reduction in small LDL, Soedamah and his coworkers found that atorvastatin only 
decreased the concentrations of large and medium LDL. In addition, both groups demonstrated 
that atorvastatin increased the size of HDL particles (Soedamah et al. 2003, Ikewaki et al. 2009). 
Positive correlations between atorvastatin therapy and size of LDL and VLDL were found, as 
well (Ikewaki et al. 2009). Furthermore, atorvastatin decreased the concentrations of medium 
and small VLDL (Soedamah et al. 2003). 
 
Simvastatin therapy has a favorable impact on HDL subclasses. Increased concentration of large 
HDL and declined concentration of intermediate HDL were seen after intake of simvastatin in 
comparison to ezetimibe (Berthold et al. 2014). 
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An interventional study showed that treatment with pravastatin decreased the concentration of 
IDL and increased the size of VLDL and LDL (Otvos et al. 2002). In addition, in this study, 
pravastatin differently affected lipoprotein subclasses of participants who had small LDL at 
baseline and participants who had large LDL at baseline. In other words, pravastatin increased 
the average size of LDL and decreased the concentration of LDL particles in subjects with small 
LDL more than in subjects with large LDL at baseline. In addition, while it did not have an effect 
on the size of HDL in subjects with large LDL at baseline, it increased the average size of HDL 
in participants who had small LDL at baseline (Otvos et al. 2002). 
 
Various statins are suggested to have different effects on concentration and size of lipoprotein 
subclasses in circulation (Rizzo & Berneis 2006). A systematic review study reported that statins 
had none to moderate effect on LDL subclasses. While limited changes were seen in LDL size 
after treatment with pravastatin and simvastatin, fluvastatin and atorvastatin had more favorable 
effects on LDL subclasses (Rizzo & Berneis 2006). In addition, a cohort study showed that the 
intake of niacin plus lovastatin decreased the concentration of smaller and denser LDL more than 
either simvastatin or atorvastatin. To be more specific, the amount of participants who shift from 
pattern B of LDL to pattern A of LDL was three or more times higher in niacin plus lovastatin 
group in comparison to atorvastatin and simvastatin groups. In addition, the higher increase in 
the proportion of larger HDL (HDL2b) was seen in subjects’ plasma after intake of niacin plus 
lovastatin as compared to simvastatin or atorvastatin (Bays & McGovern 2003). 
 
2.3.6 Diseases Related to Lipoprotein Profile 
Lipoprotein profile of plasma significantly correlates with numerous diseases most importantly, 
with CVD and type 2 diabetes. Therefore, improving the lipoprotein profile might reduce the 
prevalence or severity of these two chronic diseases.  
 
Cardiovascular diseases  
CVDs are the main reason of death not just in Europe, but also throughout the world (WHO 
2014). Several studies have revealed that the predominance of LDL type B is related to two or 
three times increased risk of CVD (Krauss 2001, Gerber & Berneis 2012). One study, considered 
it even more pathogenic by reporting sevenfold increase in the risk of CVD in subjects with 
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small LDL higher than 2.59 mmol/l (Kim et al. 2012). This correlation can be explained by four 
mechanisms. First, LDL receptors bind small LDL with less readiness. Second, the small LDL 
infiltrates easier into the wall of arteries (40-50% faster than large LDL). Third, the small LDL 
binds more tightly with the proteoglycan of arteries and fourth the small LDL oxidizes more 
quickly in comparison to large LDL (Moredich et al. 2005, Shah 2006, Kim et al. 2012).  
 
Moreover, it is proved that the HDL has protective effects on heart diseases, but further studies 
on different subclasses of HDL showed that the larger HDL is more protective than the smaller 
HDL (Felder et al. 2008). The concentration of HDL2 has had a negative association with 
progression and severity of coronary lesions. Furthermore, it was discovered that HDL2 is 
significantly lower in patients who had myocardial infarction (Pirillo et al. 2013). 
 
Type 2 Diabetes 
Diabetes or insulin resistance exerts impacts on the lipoprotein subclasses. Higher small LDL 
concentration was seen in participants with type 2 diabetes or prediabetes (Krauss 2001, Gerber 
& Berneis 2012, Magge et al. 2012, Filippatos et al. 2013). Moreover, the unfavorable profile of 
HDL (lower HDL2 and higher small HDL) have been measured in subjects with type 2 diabetes, 
poor glycemic control and prediabetes (Medina-Bravo et al. 2013, Pirillo et al. 2013, Filippatos 
et al. 2013). In addition, intensive management of glucose in patients with type 2 diabetes was 
accompanied by higher concentrations of larger VLDL, LDL and medium HDL subclasses 
besides lower concentration of small HDL (Azar et al. 2013).  
 
2.4 Diet and Lipoprotein Subclasses 
In several studies significant associations between subclasses of lipoproteins and intake of 
various nutrients or foods e.g. carbohydrates, fructose, fatty acids and alcohol have been found 
(Mukamal et al. 2007, Schaefer et al. 2009, Annuzzi et al. 2012). In this part, the impact of 
different dietary fatty acids on lipoprotein subclasses will be explained. Since the limited number 
of studies used NMR method for determining the lipoprotein subclasses, the effect of quality and 
quantity of fat intake on lipoprotein subclasses is explained in two parts. First, the effect of fat 
intake on lipoprotein subclasses determined by NMR methods. Second, the effect of fat intake on 
lipoprotein subclasses determined by methods other than NMR. In addition, tables 1, 2, 3, 4 and 
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5 show the summaries of included studies about the association between lipoprotein subclasses 
and intake of polyunsaturated fatty acids (PUFA), monounsaturated fatty acids (MUFA), 
saturated fatty acids (SFA), trans fatty acids and quantity of fat, respectively.  
 
2.4.1 Polyunsaturated Fatty Acids  
NMR Studies 
Fish and long chain n-3 fatty acids 
Fish contains long chain n-3 PUFA (eicosapentaenoic acid and docosahexaenoic acid) which can 
affect lipoprotein subclasses. Although it is agreed that the high intake of fish and diet rich in 
fatty fish cannot change the size of LDL and IDL (Li et al. 2004, Erkkila et al. 2014), there are 
conflicting evidence about the impact of fish intake on other subclasses of lipoproteins. In an 
interventional study on coronary heart disease patients, the high intake of fatty fish (4 times per 
week) increased the size of HDL (Erkkila et al. 2014). In addition, another interventional study 
in subjects with impaired glucose metabolism aimed to find the effect of diet rich in bilberries 
(300 g/day), whole grain and fatty fish (3 times per week) on the metabolic profile of serum and 
activities of lipid transfer protein. In this study, the higher intake of fish increased the 
concentration of large HDL and mean size of HDL (Lankinen et al. 2014). On the contrary, one 
intervention study showed that high fish diet (8 times per week) did not affect HDL particles 
defined by NMR (Li et al. 2004).  In addition, Li and his colleagues concluded that the 
concentration of large HDL and the size of HDL particles decreased after consumption of low 
fish diet (2 times per week). High fish diet reduced the concentrations of medium and small 
VLDL significantly, as well (Li et al. 2004). Moreover, components of large HDL changed after 
intake of a diet rich in fatty fish. Erkkila and her colleagues demonstrated that fatty fish diet 
increased the concentrations of total lipids, cholesterol and cholesterol esters in large HDL 
(Erkkila et al. 2014). The result of another study also showed that the higher intake of fish 
associated with increased concentrations of lipid components of large HDL (Lankinen et al. 
2014). 
 
In an observational study, the correlation between dietary intake of n-3 fatty acids and 
lipoprotein subclasses was investigated (Annuzzi et al. 2012). The dietary intake was measured 
by food frequency questionnaire. In addition, it should be kept in mind that EPA and DHA were 
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the two main n-3 fatty acids in this study, and they were derived from consumption of salmon 
and seal. The results of the study demonstrated that the dietary intake of n- 3 fatty acids 
associated with decreased concentration of large VLDL and smaller mean size of VLDL. 
Moreover, it associated with increased concentration of large HDL, concentration of large LDL 
and average size of HDL. In addition, the intake of n-3 fatty acids had negative correlations with 
the concentrations of small and medium HDL only in women, and it had positive correlations 
with average size of LDL and the concentration of large LDL in men. Furthermore, considering 
the fact that the intakes of carbohydrate and sugar affect lipoprotein subclasses, the impact of n-3 
fatty acids on concentration of large VLDL, concentration of large HDL and the size of VLDL 
and HDL particles remained significant even after adjustment for intake of carbohydrate and 
sugar (Annuzzi et al. 2012).  
 
The effects of daily n-3 fatty acids intake on lipoprotein subclasses were analyzed in an 
interventional study on type 2 diabetes patients (Mostad et al, 2008). In this study, intervention 
group consumed fish oil enriched with n-3 fatty acids (5.9 g/day n-3 fatty acids) and control 
group had the same amount of corn oil (8.5 g/day n-6 fatty acids). Based on the result of this 
study, n-3 fatty acids intake reduced the size of VLDL and concentrations of large VLDL and 
small HDL particles. In addition, n-3 fatty acids intake did not have any effect on the subclasses 
of LDL (Mostad et al, 2008). 
 
Furthermore, Burdge and his colleagues conducted an interventional study involving healthy 
men to find the effect of acute fish oil consumption (7.3 fold more DHA and EPA than usual UK 
diet) on lipoprotein subclasses (Burdge et al. 2009). They found that fish oil consumption 
changed significantly the size and concentration of VLDL particles. Consumption of a single 
meal rich in fish oil increased the concentration of VLDL particles and decreased the size of 
them. However, acute intake of fish oil did not have a significant effect on the size and 
concentration of LDL and HDL particles (Burdge et al. 2009). 
 
Moreover, in another study the effects of n-3 fatty acids intake on lipoprotein profile were 
analyzed by comparing the effect of n-3 fatty acids (DHA and EPA, 4g/day) plus atorvastatin 
and placebo plus atorvastatin (Maki et al. 2011). Although following changes were seen in both 
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groups, the changes were significantly greater in n-3 fatty acids group as compared to the 
placebo group.  Intake of n-3 fatty acids plus atorvastatin decreased the mean size of VLDL, 
concentrations of medium, large and total VLDL, concentrations of IDL and small LDL. In 
addition, it increased the average size of LDL, concentrations of small HDL and large HDL. On 
the contrary, concentrations of small HDL and total HDL had the larger increase in the placebo 
group in comparison to n-3 fatty acid group. Furthermore, the size of HDL particles did not 
change in either group. Finally, more participants shifted from pattern B of LDL to pattern A in 
n-3 fatty acids plus atorvastatin group as compared to the atorvastatin group (Maki et al. 2011). 
 
Usually, the intakes of EPA and DHA are analyzed together by supplementing with fish oils, 
while a randomized controlled trial aimed to find the effect of DHA on lipoprotein subclasses 
individually using 5 mg/day algal DHA oil containing 2 g DHA (Neff et al. 2011). It was found 
that DHA intake declined the average size of VLDL particles, and increased the average size of 
LDL and HDL particles. In addition, algal DHA decreased the concentrations of small LDL, 
large VLDL, medium VLDL and medium HDL particles. Higher concentrations of large LDL 
and large HDL were identified in plasma after intake of algal DHA oil, as well (Neff et al. 2011). 
 
Walnut 
Walnuts contain both n-3 and n-6 PUFA. Effects of walnut consumption on lipoprotein 
subclasses were analyzed in an intervention study by adhering study participants to four diets 
sequentially, including habitual diet (HD), habitual diet and walnuts (HD+W), low fat diet (LD),  
and lastly low fat diet and walnuts (LD+W) (Almario 2001). Dose of 48 grams walnuts per day 
was provided for the subjects who were in HD+W or LD+W diets. Eating walnuts did not 
change the size of VLDL, IDL and HDL particles, but the LD+W decreased the concentrations 
of LDL and IDL in comparison to LD. Moreover, HD+W declined the cholesterol content of 
small LDL (Almario 2001). 
 
Olive, sunflower and rapeseed oils 
An interventional study used mixture of olive, sunflower and rapeseed oils were used as sources 
of PUFA in healthy subjects. The diet of control group included 7% of energy from LA and 
0.4% of energy from ALA and the dietary fat was a mixture of olive oil, sunflower oil, rapeseed 
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oil and 25% hard stock (fully hydrogenated palm kernel and palm oil). Dietary fat of the low LA 
group (3% of energy from LA, 0.4 % of energy from ALA) consisted of 63% of olive oil, 9% of 
rapeseed oil and 28% of hard stock. Moreover, the high ALA group (7% of energy from LA, 
1.1% of energy from ALA) consumed 20% sunflower oil, 5% olive oil, 52.5% rapeseed oil and 
22.5% hard stock (Goyens & Mensink 2005). They found that the concentration of LDL 
cholesterol decreased in the high ALA group as compared to control and low LA groups. In 
addition, concentrations of VLDL subclasses decreased in both low LA and high ALA groups 
that mainly were due to decline in medium and small VLDL subclasses in low LA and high ALA 
groups, respectively. Furthermore, they did not find any changes in HDL, LDL and VLDL 
particle size. Finally, there was not any significant correlation between lipoprotein profile and 
the ratio of ALA to LA (Goyens & Mensink 2005). 
 
Other Methods 
In an observational study on healthy sedentary men the associations between diet and 
lipoproteins subclasses were analyzed (Williams et al. 1986). It was found that PUFA intake had 
negative correlations with concentrations of VLDL and LDL cholesterol. In addition, higher 
intake of PUFA significantly associated with lower concentrations of small LDL, small IDL and 
small VLDL particles. All of the mentioned correlations except for small VLDL were significant 
after adjustment for age, percentage of body fat and cigarette use. On the contrary, a cross-
sectional study showed that PUFA consumption was positively associated with the size of LDL 
particles only in patients with type 2 diabetes or impaired glucose metabolism and not in a 
person with a normal glucose metabolism (Bos et al. 2007).  
 
On the basis of a cross-sectional study, Bogl and her colleagues concluded that the twins who 
consumed higher amounts of n-3 fatty acids had higher concentration of large HDL and lower 
concentration of small HDL in comparison to their co-twins with lower consumption of n-3 fatty 
acids (Bogl et al. 2011). In addition, the substitution of one energy percentage from n-3 fatty 
acids for other kinds of fat had significant correlation with larger mean size of HDL. They did 
not find any significant correlation between intake of n-3 fatty acids and LDL particle size. 
Moreover, in some interventional studies the effects of DHA and EPA supplementations on 
lipoprotein subclasses were analyzed. Intake of n-3 fatty acid supplements (4g/day from 60% 
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EPA, 40% DHA) increased the concentration of HDL2, but it did not affect the LDL 
subpopulations in active males (Thomas et al. 2004). In a crossover study, participants consumed 
3 different kinds of capsules, including capsules containing control oil, capsules containing 1.8 g 
EPA+DHA/ day or capsules containing 0.7 g EPA+ DHA/ day in a randomized order. The 
results of this study showed that even moderate intake of EPA and DHA from fish oil increased 
the concentrations of HDL2, total HDL and total LDL (Caslake et al. 2008). In addition, the 
lower VLDL cholesterol concentration was seen in plasma after moderate intake of DHA and 
EPA (Caslake et al. 2008). Furthermore, the effect of DHA was analyzed individually. Based on 
a result of a randomized control trial study on hyperlipidemic children, DHA consumption 
(1.2g/day) increased the concentrations of large LDL by 91% and large HDL by 14%. DHA 
intake decreased the concentration of small LDL by 48% in these children, as well (Engler et al. 
2005). 
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Table 1. Summary of included studies about the association between intake of PUFA and lipoprotein subclasses. 
Author Study design 
Participants/ 
Sample size 
Interventions 
Method of 
determining 
lipoprotein 
subclasses 
Main findings 
1. Interventions 
Almario 
2001 
Interventional 
study 
18 subjects (5 
men and 13 
postmenopausal 
women; age 60± 
8 y) 
1) habitual diet for 4 weeks, 2) habitual diet plus 
walnuts for 6 weeks, 3) low fat diet for 6 weeks and 4) 
low fat diet plus walnuts for 6 weeks.  
NMR 
Habitual diet plus walnuts ↓ the cholesterol content of 
small LDL in comparison to habitual diet.  
Burdge et 
al. 2009 
Interventional 
study 
11 healthy men 
(age 58± 5 y) 
1) Reference meal or usual UK diet and 2) meal 
enriched with fish oil in a random order. There were at 
least 14 day washout periods. 
NMR 
Meal rich in fish oil ↓ the mean size of VLDL particles 
during postprandial period. It did not affect the LDL 
and HDL particles. 
Caslake 
et al. 
2008 
Randomized, 
Double- blind, 
placebo- 
controlled 
crossover study  
312 adult 
subjects (age 20-
70 y) 
1) Capsules contained EPA+ DHA (0.7/day), 2) 
capsules contained EPA+DHA (1.8 g/day) and 3) 
capsules contained control oil in a random order and 
for 8 weeks. There was 12 week washout period. 
nondenaturing 
gradient gel 
electrophoresis 
Fish oil ↑ the concentrations HDL2. 
Engler et 
al. 2005 
Randomized, 
double-blind, 
placebo-
controlled, 
crossover  study 
20 children with 
hyperlipidemia. 
(age 9-19 y) 
1) 1.2 g/day of DHA or 2) 1.2g/day of placebo for 6 
weeks. 
Vertical Auto 
Profile II 
DHA significantly ↑ the concentrations of large LDL 
by 91% and ↓ the concentration of small LDL by 48%. 
It ↑ the concentration of large HDL by 14%. 
Erkkila et 
al. 2014 
Randomized, 
controlled, 
Parallel study 
33 patients with 
coronary heart 
disease (age 61.0 
± 5.8 y) 
1) Fatty fish diet (from fish likes salmon, rainbow and 
trout), 2) lean fish diet (from fish like pike, perch and 
cod) or 3) control diet (from lean beef, pork and 
chicken instead of fish) for 8 weeks. 
NMR 
Concentrations of total lipid, cholesterolester and, 
cholesterol in very large HDL ↑ after intake of fatty 
fish diet and ↓ after consumption of control and lean 
fish diets. Fatty fish diet ↑ mean size of HDL. Fish 
diets did not affect VLDL and IDL particles. 
Goyens 
& 
Mensink 
2005 
Randomized, 
double-blind, 
controlled, parallel 
study 
54 subjects 
including 21 men 
(age 52.6± 13.7 
y) and 33 women 
(age 47.7± 11.1 
y) 
1) Control diet, 2) low LA diet or 3) high ALA diet 
for 6 weeks. 
NMR 
Concentration of VLDL particles ↓ in low LA and high 
ALA groups. This reduction was mainly due to ↓ of 
medium VLDL in the low LA group and small VLDL 
in the high ALA group.  
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Author Study design 
Participants/ 
Sample size 
Interventions 
Method of 
determining 
lipoprotein 
subclasses 
Main findings 
Lankinen 
et al. 
2014 
Randomized, 
controlled, 
Parallel study  
131 subjects with 
impaired glucose 
metabolism and 
features of 
metabolic 
syndrome (age 40-
70 y) 
1) Healthy diet (fatty fish, bilberries, whole grain and 
grain product with low postprandial insulin response), 
2) WGED diet (whole grain and low postprandial 
insulin response grain product) or 3) control diet 
(refined wheat bread) for 12 weeks. 
NMR 
Higher intake of fish associated with larger size of 
HDL particles, increased concentrations of lipid 
components of large HDL and higher concentration of 
large HDL.  
Li et al. 
2004 
Interventional 
study  
22 men and 
women (age> 40 
y) 
1) High fish diet or 2) low fish diet for 24 weeks.  NMR 
High fish diet ↓ the concentration of medium and small 
VLDL. Low fish diet ↓ the large HDL and the size of 
HDL particles. 
Maki et 
al. 2011 
Randomized, 
double-blind, 
placebo-
controlled, parallel 
study 
245 subjects with 
mixed 
dyslipidemia (18-
79 y) 
1) POM3 (prescription of omega-3 acid) plus 
atorvastatin (10 mg/day) or placebo plus atorvastatin 
(10mg/day) for 8 weeks.  
2) Elevated dosage of atorvastatin (20mg/day) for 4 
weeks.  
3) Elevated dosage of atorvastatin (40 mg/day) for 4 
weeks.  
NMR 
The lower concentration of small LDL particles, higher 
concentration of larger LDL particles and larger mean 
size of LDL were seen after intake of POM3 diet as 
compared with placebo diet. More participants shifted 
from pattern B of LDL to pattern A in POM3 group as 
compared to the placebo group.  
Mostad 
et al, 
2008 
Randomized, 
placebo 
controlled, parallel 
study 
26 subjects with 
normal TG level 
and type 2 diabetes 
without insulin 
treatment (age 40-
75 y) 
1) Fish oil diet or 2) corn oil diet for 9 weeks.  NMR 
n-3 fatty acid ↓ the mean size of VLDL, concentrations 
of large VLDL and small HDL (without correlation 
with reduction of insulin sensitivity). It did not affect 
LDL particles. 
Neff et 
al. 2011 
Randomized, 
Double blind,  
controlled, parallel 
study 
36 healthy, obese 
or overweight 
subjects (18-65 
y) 
 
1) Algal DHA oil or 2) placebo (an oil mixture of corn 
and soybean) for 4.5 months.  
NMR 
Smaller mean size of VLDL, larger mean size of HDL 
and LDL were seen in participants who consumed 
DHA diet in comparison to the placebo group. Intake 
of DHA also ↑ the concentrations of large LDL and 
large HDL, and ↓ the concentrations of small LDL and 
medium HDL. 
Thomas 
et al. 
2004 
Interventional 
study 
10 active males 
(age 25± 1.5 y) 
1) n-3 fatty acids for 4 weeks. 
2) 60 minutes treadmill exercise before and after 4 
weeks supplementation. 
Modified 
heparin- 
MnCl2-
dextran sulfate 
and Lipoprint 
methods 
N-3 fatty acid supplementation ↑ the concentrations of 
HDL2. The size of LDL particles and concentrations of 
LDL subclasses did not change by intake of n-3 fatty 
acids. Intake of n-3 fatty acids and exercise ↑ the 
concentration of HDL3 and LDL1 in comparison to 
baseline measurements. 
2. Observational Studies 
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Author Study design 
Participants/ 
Sample size 
Interventions 
Method of 
determining 
lipoprotein 
subclasses 
Main findings 
Annuzzi 
et al. 
2012 
Cross-sectional 
study 
977 subjects (age 
women 40.7± 
15.2, men 41.2± 
14.8 y) 
- NMR 
After adjustment for potential confounders (age, BMI, 
total energy intake and percentage of energy from fat), 
intake of n-3 significantly correlated with lower 
concentration of large VLDL and smaller size of 
VLDL particles, higher concentration of large HDL 
and larger size of HDL particles. The correlations 
remained significant after adjustment for carbohydrate 
and sugar. 
Bogl et 
al. 2011 
Cross-sectional 
study 
24 healthy twin 
pairs (age 23-33 
y) 
- 
Non-
denaturing 
gradient gel 
electrophoresis 
The consumption of one percent of energy from n-3 
fatty acid instead of other kinds of fats was correlated 
with larger mean size of HDL in both genders. This 
relation remained significant after controlling the effect 
of genetic and shared environment by within- pair 
comparison in twin pairs.  
Bos et al. 
2007 
Cross-sectional 
study 
758 subjects with 
normal, impaired 
glucose 
metabolism and 
type II diabetes 
- 
Gel-filtration 
chromatograph
y 
PUFA intake negatively correlated with size of LDL in 
participants with type 2 diabetes and in subjects with 
impaired glucose metabolism. 
Williams 
et al. 
1986 
Cross-sectional 
study 
77 healthy, 
sedentary men 
(age 30-55 y) 
- 
Analytical 
ultracentrifuga
tion 
Higher intake of PUFA negatively correlated with 
concentrations of smaller LDL, IDL and VLDL 
particles. 
PUFA= Polyunsaturated fatty acids, DHA= Docosahexaenoic acid, EPA= Eicosapentaenoic acid, LA= Linoleic acid, ALA= Alpha linolenic acid. 
21 
 
  
2.4.2 Monounsaturated Fatty Acids 
NMR method 
Perez-Martinez and his coworkers demonstrated that subjects who ate a meal rich in olive oil 
(36% of energy from MUFA) had more favorable lipoprotein profile in comparison to 
participants who took a meal rich in butter (35% of energy from SFA) and walnuts (16% of 
energy from PUFA). It was found that a meal rich in MUFA increased the size of TG rich 
lipoproteins more than a meal rich in PUFA. In addition, lower number of TG rich lipoproteins 
were seen after consumption of MUFA as compared to SFA and PUFA (Perez-Martinez et al. 
2011). On the contrary, results of an interventional study showed that the intake of these diverse 
fatty acids did not have significantly different effects on the lipoprotein subclasses (Thijssen & 
Mensink 2008). In this study, participants used 3 different diets in a random order for 5 weeks. 
The compositions of diets were similar except for 7% of energy that came from oleic acid 
(MUFA), stearic acid (SFA) or linoleic acid (PUFA) (Thijssen & Mensink 2008). 
 
Other Methods 
A cross-sectional study on relations of lifestyle factors and lipoprotein subclasses revealed that 
the ratio of cholesterol in small LDL to cholesterol in large buoyant LDL had negative 
correlation with intake of MUFA (Parlesak et al. 2014). It was in agreement with an 
interventional study, which was done by Zambon and his colleagues. In that study, participants 
randomly consumed high carbohydrate hypocaloric diet (60% of calories from complex 
carbohydrate, and 25% of calories from fat, which contained 10% from SFA, 7% from MUFA, 
8% from PUFA) or olive oil enriched hypocaloric diet (40% of calorie from complex 
carbohydrate, 45% of calories from fat which contained 10% from SFA, 27% from MUFA and 
8% from PUFA) for 6 months. Lower concentration of small and dense LDL and lower ratio of 
LDL to HDL cholesterol were seen in plasma after 6 months’ consumption of high MUFA diet. 
In addition, high MUFA diet increased the cholesterol content of HDL2 particles while it did not 
have any effect on cholesterol content of HDL3. Moreover, both diets decreased the 
concentration of LDL cholesterol and weight of the participants (Zambon et al. 1999). 
Furthermore, in an interventional study in moderately hypercholesterolemic subjects the impact 
of MUFA as a replacement for SFA on lipoprotein subclasses’ profile was assessed. In this 
study, participants consumed low MUFA diet (7.8% of energy from MUFA and 14.7% of energy 
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from SFA), moderate MUFA diet (10.3% of energy from MUFA and 11.2% of energy from 
SFA) and high MUFA diet (13.7% of energy from MUFA and 7.3% of energy from SFA) for 6 
weeks in random order. The higher consumption of MUFA decreased the concentrations of total 
LDL, small LDL and large LDL. Higher intake of MUFA did not have a significant effect on the 
distribution of LDL particles and lower concentration of small and large LDL were due to lower 
concentration of total LDL cholesterol after higher intake of MUFA. Since the higher intake of 
MUFA in this study was accompanied with the lower intake of SFA, it was not clear if this 
reduction happened due to reduction of SFA in diet, or an increase of MUFA in diet or even a 
combination of both of them (Gill et al. 2003).
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Table 2. Summary of included studies about the association between intake of MUFA and lipoprotein subclasses. 
Author Study design 
Participants/ 
Sample size 
Intervention 
Method of 
determining 
lipoprotein 
subclasses 
Main findings 
1. Interventions   
Gill et al. 
2003 
Interventiona
l study 
35 subjects with 
moderate 
hypercholesterolm
ia (17 men and 18 
women, age 55± 
5.6 y) 
1) Low MUFA diet, 2) moderate MUFA diet and 3) 
high MUFA diet for 6 weeks and in a random order. 
There were at least 8 week washout period.  
Dextran sulfate-
magnesium 
chloride dual-
precipitation, 
gradient 
ultracentrifugati
on, 
discontinuous 
density gradient 
centrifugation 
The distribution of LDL subclasses did not change by 
consumption of various amounts of MUFA. However, since 
LDL cholesterol ↓ with higher intake of MUFA in a dose 
response trend, the higher intake of MUFA ↓ the 
concentration of LDL2 and LDL3 by 21.5 and 24.5% 
respectively. 
Perez-
Martinez 
et al. 
2011 
Randomized 
crossover 
study 
20 men (age 22± 
1.8 y) 
1) Butter meal, 2) olive oil meal and 3) walnut meal. 
Mentioned meal had 1g fat and 7 mg cholesterol per 
kg body weight.  
NMR 
Olive oil meal ↓ the number of TRL particles in comparison 
to other meals. Olive oil meal also ↑ the mean size of TRL 
particles as compared to walnut meal. 
Thijssen 
& 
Mensink 
2008 
Randomized,  
crossover 
study 
45 participants (27 
women, 18 men, 
age 28–66 y) 
7% of energy in various diets was obtained from 1) 
stearic acid, 2) oleic acid or 3) linoleic acid. The 
duration of each diet was 5 weeks 
NMR 
No significant changes were found in the concentration and 
mean size of lipoprotein subclasses among various diets.  
Zambon 
et al. 
1999 
Interventiona
l study 
34 
normolipidemic, 
premenopausal 
women (age 22-39 
y) 
1) High carbohydrate hypocaloric diet or 2) olive oil 
enriched hypocaloric diet for 6 months. 
Density 
gradient 
ultracentrifuga
tion 
High MUFA diet ↑ cholesterol in HDL2. The concentration 
of small LDL ↓ significantly after intake of high MUFA 
diet. The concentration of HDL3 did not change after 
consumption of both diets. 
Observational Studies 
Parlesak 
et al. 
2014 
Cross-
sectional 
study 
265 healthy men 
(20-67 y) 
- 
Ultracentrifuga
tion 
Higher intake of MUFA associated with lower ratio of 
cholesterol in small dense LDL to cholesterol in large 
buoyant LDL.  
MUFA= monounsaturated fatty acids and TRL= Triacylglycerols-rich lipoproteins
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2.4.3 Saturated Fatty Acids  
There was not any article published about the effect of SFA intake on lipoprotein subclasses 
determined by NMR method, except as control group in previously mentioned studies. 
 
In an interventional study the effects of low fat (24% of energy from fat, 6% SFA, 12%MUFA 
and 4% PUFA) versus high fat diet (46% of energy from fat, 18% SFA, 13% MUFA, 12% 
PUFA) on lipoprotein subclasses were explored. It was found that the higher consumption of 
SFA (myristic and palmitic acids) correlated with higher concentration of large LDL and larger 
mean size of LDL particles. Intake of SFA also had significant, negative correlation with 
concentration of small LDL (Dreon et al. 1998). In addition, in a cross-sectional study involving 
healthy men, Sjogren and his colleagues indicated that pentadecanoic acid, 15:0 and 
heptadecanoic acid, 17:0 derived from milk products had negative correlation with concentration 
of small LDL particles (Sjogren et al 2004).
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Table 3. Summary of included studies about the association between intake of SFA and lipoprotein subclasses. 
Author Study design 
Participants/ 
Sample size 
Intervention 
Method of 
determining 
lipoprotein 
subclasses 
Main findings 
1. Interventions  
Dreon et 
al. 1998 
Randomized 
Crossover 
study 
103 healthy men 
(age>20 y) 
1) High fat diet or 2) low fat diet for 6 weeks.  
Analytic 
ultracentrifuga
tion and 
Nondenaturing 
polyacrylamid
e gradient gel 
electrophoresis 
Higher intake of SFA correlated with a lower concentration 
of small LDL, higher concentration of large LDL and larger 
mean size of LDL particles. 
2. Observational Studies 
Sjogren 
et al 2004 
Cross-
sectional 
study 
291 healthy men 
(age 63± 0.6 y) 
- 
Polyacrylamid
e gradient gel 
electrophoresis
, protein-
staining 
Higher intake of pentadecanoic acid and heptadecanoic acid 
correlated with a lower concentration of small LDL. 
SFA= saturated fatty acids
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2.4.4 Trans Fatty Acids  
NMR Studies 
In an interventional study the effects of industrially produced trans fatty acids intake and natural 
trans fatty acids intake on lipoprotein subclasses were compared (Chardigny et al 2008). It was 
found that the consumption of industrially produced trans fatty acids decreased the number of 
HDL particles, especially by reduction of large HDL particles in women. In addition, the women 
consuming trans fatty acids from natural sources had higher LDL cholesterol as compared to 
women who ate industrially produced trans fatty acids. This increase was due to increase in the 
concentration of large LDL (Chardigny et al. 2008). 
 
Other Methods 
There is a debate over the effect of trans fatty acid on lipoprotein subclasses defined by methods 
other than NMR. In an interventional study 5 different diets (all of them contained 30% of 
energy from fat) were used in a random order for 35 days. In each diet two thirds of fat were 
supplied by different fat in which the amount of trans fatty acids ranged from 0.6 g trans fatty 
acids/100 g fat to 26.1 g trans fatty acids/100 g fat. The result of this study showed that the 
higher dietary intake of trans fatty acids decreased the size of LDL particles in a dose dependent 
fashion. Furthermore, higher intake of trans fatty acids increased the cholesterol content of small 
and medium LDL (Mauger et al. 2003). Contradicting this result, in a cross-sectional study, Kim 
and Campos reported that trans fatty acids intake positively correlated with size of LDL particles 
(Kim & Campos 2003). It should be mentioned that the first interventional study can explain the 
causal relation better than the second observational study. In other words, since the researchers 
have control over the exposure in an interventional study, the isolated effect of exposure on 
outcome can be analyzed (DiPietro 2010). 
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Table 4. Summary of included studies about the association between intake of trans fatty acids and lipoprotein subclasses. 
Author Study design 
Participants/ 
Sample size 
Intervention 
Method of 
determining 
lipoprotein 
subclasses 
Main findings 
1. Interventions  
Chardign
y et al 
2008 
Randomized, 
double-blind, 
controlled, 
crossover 
study  
46 healthy 
participants, 
including 22 men 
and 24 women 
(age 27.6± 7.1) 
1) Industrially produced trans fatty acids and 2) 
natural trans fatty acid for 3 weeks. There was a week 
washout period. 
NMR 
Natural sources of trans fatty acid ↑ the concentration of 
large HDL cholesterol and ↓ the concentrations of large 
LDL cholesterol in women in comparison to industrially 
produced trans fatty acids. 
Mauger 
et al. 
2003 
Interventiona
l study 
36 subjects, 18 
men and 18 
postmenopausal 
women (age 63± 6 
y) 
5 different diets in random order for 35 days. Two 
third of fat in various diets were provided by products 
with different level of trans fatty acids, including 1) 
semiliquid margarine, 2) soft margarine, 3) 
shortening, 4) stick margarine and 5) butter. 
Nondenaturing
, 2–16% 
polyacrylamid
e gradient gel 
electrophoresis 
Higher intake of trans fatty acids ↓ the mean size of LDL 
particles in dose response manner. The concentrations of 
cholesterol in large and medium LDL ↑ with higher intake 
of trans fatty acids.   
2. Observational studies 
Kim & 
Campos 
2003 
Cross- 
sectional 
study 
414 subjects  
 
- 
Gradient gel 
electrophoresis 
on 2% to 16% 
no denaturing 
polyacrylamid
e gels 
The mean size of LDL particles had positive correlation 
with intake of trans fatty acids. This correlation remained 
significant even after adjustment for potential confounders 
including age, gender, energy intake, BMI, LDL, HDL and 
TG. 
TG= Triglycerides
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2.4.5 Quantity of Fat 
NMR Studies 
An interventional study aimed to estimate the effects of reduced carbohydrate diet and reduced 
fat diet on lipoprotein subclasses in overweigh and obese healthy subjects (LeCheminant et al. 
2010). In the first 3 months of the study all of the participants consumed a very low energy diet 
to lose weight. Then, in next 9 months, participants consumed either reduced carbohydrate diet 
(around 20% of energy from carbohydrate) or reduced fat diet (around 30% of energy from fat) 
to maintain weight. LeCheminant and his colleagues found that the reduced fat diet significantly 
increased the concentrations of total, large and small HDL. It increased the concentrations of 
total, large, medium and small VLDL, as well. In addition, the amount of weight loss was not 
different between reduced fat diet and reduced carbohydrate diet groups (LeCheminant et al. 
2010).  In another study, overweight subjects were randomized into either low carbohydrate, 
ketogenic diet (lower than 20 g carbohydrate /day) or low fat diet (lower than 30% of energy 
from fat and lower than 300 mg of cholesterol per day) (Westman 2006). According to this 
study, low fat diet decreased the concentrations of large VLDL, small LDL and LDL particles. 
Furthermore, low fat diet increased the concentration of large HDL and average size of LDL and 
HDL particles. In addition, it should be mentioned that the weight of the participants reduced by 
consumption of both diets (Westman 2006). Moreover, in an interventional study that involved 
hyperlipidemic patients for 8 weeks, the concentration of small LDL increased by 36% after 
intake of low fat diet (30% of energy from fat with intake of trans fatty acid and SFA lower than 
10%) (Stoernell et al. 2008). 
 
The acute effect of a high fat meal on lipoprotein subclasses was assessed in an interventional 
study (Wojczynski et al 2011). It was found that while the concentration of total LDL particles 
and small LDL decreased due to consumption of a high fat meal (83% of energy from fat, 14% 
of energy from carbohydrate and 3% of energy from protein), this meal increased the 
concentration of large LDL in plasma. In addition, high fat meal decreased the concentrations of 
total VLDL, medium and small VLDL particles. High fat meal increased the concentrations of 
total HDL and medium HDL in men, but it did not affect large HDL. Furthermore, the lower 
concentration of small HDL particles and higher concentration of medium HDL particles were 
seen in women’s plasma in response to a high fat meal (Wojczynski et al 2011).   
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Other Methods 
An interventional study involving men on low fat (24% of energy from fat, 60% of energy from 
carbohydrate) and high fat diets (46% of energy from fat, 38% of energy from carbohydrate) 
showed that lower intake of fat decreased HDL3a, HDL2a and HDL2b concentrations (William 
et al. 1995). In addition, it decreased the peak diameter and mean diameter of HDL. It should be 
mentioned that changes in the mean diameter of HDL and concentration of HDL2b were greater 
in men with LDL pattern A than those with LDL pattern B (William et al. 1995). 
 
In an interventional study on healthy, non-obese males with normal lipid profile effects of short 
term, high fat versus low fat diet consumption on lipoprotein subclasses were analyzed (Guay et 
al. 2012). Participants consumed two different diets, including high fat diet (37% of energy from 
fat and 50% of energy from carbohydrate) and low fat diet (25% of energy from fat and 62% of 
energy from carbohydrate) for three days in random order. High fat diet increased the size of 
LDL particles, concentration of medium LDL and cholesterol content of large and medium LDL 
particles as compared to low fat diet. In addition, the concentration of small LDL particles 
decreased after intake of high fat diet in comparison to low fat diet (Guay et al. 2012). 
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Table 5. Summary of included studies about the association quantity of fat intake and lipoprotein subclasses. 
Author Study design 
Participants/ 
Sample size 
Intervention 
Method of 
determining 
lipoprotein 
subclasses 
Main findings 
1. Interventions  
Guay et 
al. 2012 
Randomized, 
double-blind, 
crossover 
study 
12 healthy and 
non-obese men 
with normal 
plasma lipid 
profile (age 27.1± 
3.9 y) 
1) High fat diet (37% of energy from fat and 50% of 
energy from carbohydrate) and 2) low fat diet (25% of 
energy from fat and 62% of energy from 
carbohydrate) for 3 days. There were 2 week washout 
period. 
Polyacrylamid
e gradient gel 
electrophoresis 
High fat diet ↑ the mean size of LDL particles in 
comparison to low fat diet. High fat diet ↓ the concentration 
of small LDL particles.  
LeChemi
nant et al. 
2010 
Quasi-
experimental 
study 
35 healthy, obese 
or overweight, 
middle age 
subjects 
1) Reduced carbohydrate diet (around 20% of energy 
from carbohydrate) or 2) reduced fat diet (around 30% 
of energy from fat) for 9 months.  
NMR 
Both diets ↑ the concentrations of large and small HDL and 
large VLDL.  
Restricted fat diet ↑ the concentration of medium and small 
VLDL, as well. The amount of weight loss was not 
significantly different between and within groups.  
Stoernell 
et al. 
2008 
Randomized,  
parallel 
study 
 
28 
hypertriglyceride
mic participants  
1) Low carbohydrate (15% of energy from 
carbohydrate and 55-65% of energy from fat) or 2) 
low fat diets (50-60% of energy from carbohydrate 
and 30% of energy from fat, lower than 10% of 
energy from SFA and trans fatty acids) for 8 weeks. 
NMR Low fat diet ↑ the concentration of small LDL by 36%.  
Westman 
2006 
Randomized, 
parallel 
study 
119 healthy, 
hyperlipidemic, 
overweight or 
obese subjects 
(age: 18-65 y) 
1) Low carbohydrate, ketogenic diet (lower than 20g 
charbohydrate/ day) or 2) low fat, low calorie diet 
(lower than 30% of energy from fat, lower than 300 
mg cholesterol/ day) for 6 months. 
NMR 
Low fat diet ↓ the concentrations of large VLDL, small 
LDL and LDL particles. It ↑ the concentration of large 
HDL and the mean size of LDL and HDL particles in 
comparison to baseline measurements.  
William 
et al. 
1995 
Randomized 
Crossover 
study  
105 men (age 48.9 
±11. 1 y) 
1) Low fat diet (24% of energy from fat and 60% of 
energy from carbohydrate) and 2) high fat diet (46% 
of energy from fat and 38% of energy from 
carbohydrate) for 6 weeks.  
Gradient-gel 
electrophoresis 
Low fat diet ↓ the concentrations of HDL3a, HDL2a and 
HDL2b, mean size of HDL and peak diameter of HDL 
particles in comparison to high fat diet. The higher amount 
of reduction in concentration of HDL2b and mean diameter 
of HDL was seen in men with LDL pattern A than those 
with LDL pattern B. 
Wojczyn
ski et al 
2011 
Interventiona
l study 
1048 subjects  
(age: 18-87 y) 
high fat meal (83% of energy from fat, 14% of energy 
form carbohydrate and 3% of energy from protein) 
NMR 
High fat meal ↓ the number of total LDL particles after 6 
hours and the highest amount of ↓ was seen for the number 
of small LDL. High fat meal also ↓ the total number of 
VLDL particles owing to reduced concentration of medium 
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and small VLDL. It ↑ the concentration of large VLDL and 
chylomicron among men with normal TG level.  
SFA= Saturated fatty acids
32 
 
  
3. OBJECTIVES 
The main aim was to study the association between the quality and quantity of dietary fat intake 
and lipoprotein subclasses in postmenopausal women older than 65 years.  
The specific aim was to study the association of SFA, MUFA, n-3 and n-6 PUFA intake with 
lipoprotein subclasses in plasma. 
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4. METHODS 
This study was based on the baseline data of Osteoporosis Risk Factor and Prevention- Fracture 
Prevention Study (OSTPRE-FPS) (Kärkkäinen et al. 2010). It was an intervention study that 
began in 2003 and lasted for 3 years. OSTPRE-FPS was planned to analyze the impact of 
calcium and vitamin D supplementation on falls and fractures in postmenopausal women older 
than 65 years. OSTPRE-FPS was accepted by a research ethics committee of Kuopio University 
Hospital in October 2001. Moreover, participants completed paper based informed consent form 
at baseline (Kärkkäinen et al. 2010). 
 
4.1 Participants  
The participants of this study were part of the population based OSTPRE cohort of women who 
were born in 1932-1941. The interest of participation in the study was asked by postal enquiries 
from August to December of 2002. Minimum age of 65 years at the end of November 2002 and 
residing in Kuopio during trial were inclusion criteria of the study. In this study 3432 
volunteering women with 63.5% response rate were participated (Kärkkäinen et al. 2010). From 
this population, 750 participants were asked to have laboratory tests and fill 3 days food records 
at baseline. Dietary food records of 554 participants were valid for analysis (Järvinen et al. 
2012). 
 
4.2 Baseline Measurements 
Baseline measurements started in February 2003 and finished in May 2004. Anthropometric 
measurements were done at baseline. Weight was measured by a digital calibrated scale (Philips, 
type HF 351/00) and height was determined by calibrated wall meter. In addition, BMI was 
calculated dividing weight (in kg) by the square of height (in meters) (Kärkkäinen et al. 2010). 
Furthermore, lifestyle and health information such as intake of dietary supplements and 
medications, physical activity, disease status, menopause time, smoking and alcohol intake were 
asked through self-administrated postal questionnaire at baseline (Jarvinen et al. 2012. 
Participants were asked if they had a diagnosed diabetes treated with insulin, oral diabetic 
medications or diet.  
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4.3 Lipoprotein Subclasses 
Blood samples of participants who were fasted for at least 10 hours were collected at baseline, 
and the lipoprotein subclasses were assessed by the NMR spectroscopy method. Bruker 
AVANCE 3 spectrometer, which work at 500.36 MHz was used for measuring the NMR 
information. Serum of blood sample was separated by centrifugation. 300 l of each sample was 
mixed with 300 l of sodium phosphate buffer. Next, the automatic sample preparation was done 
by the Gilson Liquid Handler. In this procedure at first, 300 l of buffer was added to the NMR 
tubes, then 300 l of serum was transformed to the tube. After that, aspirating mixed it 
completely. 
 
Serum metabolome was detected via three different molecular windows (LIPO, LMWM and 
LIPID). The LIPO and LMWM were run from the native serum sample in a same experiment 
and the LIPID data from lipid extracts afterwards. LIPO windows illustrate the wide range of 
overlapped resonances that are mostly derived from various lipid molecules in different 
lipoprotein particles. These data were collected by 80 k data points after four dummy scans that 
used eight transients. LMWM shows signals from low molecular weight metabolites and LIPID 
window provides detailed molecular information on serum lipids (Inouye et al. 2010). 
 
In this study, we used data only from LIPO window, which includes concentrations of 
lipoprotein particles, including chylomicrons, extremely large VLDL, very large VLDL, large 
VLDL, medium VLDL, small VLDL, very small VLDL, IDL, large LDL, medium LDL, small 
LDL, very large HDL, large HDL, medium HDL and small HDL. Moreover, amounts of total 
lipid, phospholipid, total cholesterol, cholesterol ester, free cholesterol and triglyceride in 
mentioned lipoprotein subclasses were measured. Mean diameters of VLDL, LDL and HDL 
particles were measured, as well.  
 
4.4 Dietary Habits 
Participants were asked to fill out 3 days’ food record at baseline. The instruction of filling 
records and food record were sent to the women, and the subjects were asked to bring the 
complete form on the research visit. It was demanded to fill the records in 3 successive days (2 
weekdays and 1 weekend). Regards to fat intake, questions were asked about the quality of fat 
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consumed in bread, cooking, and baking. Furthermore, participants were asked to recall 
frequency of fish consumption and nutritionist asked about the unclear parts of the diaries 
through phone calls. Five hundred and fifty four participants returned the dietary records. 
Finally, the intakes of nutrients were calculated by Nutrica program version 2.5 (Finnish social 
insurance institute, Turku. Finland) (Jarvinen et al. 2012). 
 
4.5 Statistical Analysis 
Data were analyzed by IBM SPSS statistics software (version 21). Mean ± SD, and valid 
percentage are reported. Normality of variables was checked by the Kolmogorov-Smirnov test, 
and the skewed variables were transformed by log 10 transformation. Transformed variables 
were used for the analysis, but back transformed means are reported. The Pearson correlation 
coefficient was used to analyze the correlations between normally distributed dietary factors and 
lipoprotein subclasses. The Spearman correlation coefficient was used to evaluate the 
correlations between non-normally distributed dietary factors and lipoprotein subclasses. 
Frequency of fish intake was classified into three categories, including no use or once per month, 
0.5-1 times per week and two or more times per week. Kruskall-Wallis test was used to test the 
differences in distribution of VLDL and HDL subclasses among the categories of fish intake. 
The relation between tertiles of SFA (E%) and lipoprotein subclasses was analyzed by 
ANCOVA test with adjustment for physical activity, BMI, age, smoking and intake of lipid 
lowering drugs. However, unadjusted mean is reported. The Bonferroni test was conducted to 
test the pairwise differences. It should be mentioned that since the participants were elderly 
women who did not have a lot of physical activity, the physical activity was categorized into two 
categories, including two times or less per week and more than three times per week. In addition, 
smoking status was categorized into current smoker and not current smoker. The level of 
significance was set to p value less than 0.05 for all of the tests, and 2 tailed p values were 
reported.  
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5. RESULT 
5.1 Basic Characteristics 
Clinical and biochemical characteristics of participants are shown in Table 6. Altogether, 555 
mostly nonsmoker women participated in the study. Mean BMI of participants was in the 
overweight range. In addition, there were not a lot of variations in the age of participants. Almost 
half of the participants had hypertension. Various kinds of diabetes were seen in 9.3 percent of 
participants. CHD was the most predominant heart problem in the sample group. In addition, 
around 25 percent of the population used the lipid lowering drug.  
 
Table 6. Clinical and biochemical characteristics of participants1. 
Women   (n=555) 
Age (y)2 67.85± 1.87 
BMI (kg/m2)2 28.77± 4.73 
Current smoker (%)3 5.4 
Hypertension (%) 41.1 
Coronary heart diseases (%) 16.6 
Stroke (%) 1.1 
Transient ischemic attack (%) 6.8 
Other heart disease (%) 8.8 
High serum cholesterol (%) 31.9 
Diabetes treated with insulin (%) 1.8 
Diabetes treated with oral medication (%) 4.1 
Diabetes treated with diet (%) 3.4 
Intake of lipid lowering drugs (%) 24.7 
Physical activity 2 times or less per week (%) 40.4 
Physical activity more than 3 times per week (%) 59.6 
1Mean ± SD is reported for continuous variable and valid percentage for categorical variables. 
2n= 554 
3n= 503 
 
Table 7 shows the distribution of lipoprotein subclasses in the population. According to the table, 
the concentration of 14 lipoprotein subclasses were measured. The concentration of very small 
VLDL was more than other subclasses of VLDL. Large LDL had the highest concentration, and 
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medium LDL had the lowest concentration between subclasses of LDL. Furthermore, although 
the highest proportions of total lipid, total cholesterol, cholesterol ester and free cholesterol were 
seen in large LDL, the greatest amount of phospholipid and triglycerides were seen in small 
HDL and medium HDL, respectively. In addition, extremely large VLDL had the lowest 
proportion of total lipid, phospholipid, total cholesterol, cholesterol ester and free cholesterol. 
The lowest amount of triglycerides was seen in very large HDL, as well.  
 
Table 7. Lipoprotein subclasses of participants. 
women (n=547) 
VLDL  
Concentration of chylomicrons and extremely large VLDL particles (nmol/l) 0.13± 0.11 
Total lipids in chylomicrons and extremely large VLDL (mmol/l)  0.028± 0.025 
Phospholipids in chylomicrons and extremely large VLDL (mmol/l) 0.003± 0.003 
Total cholesterol in chylomicrons and extremely large VLDL (mmol/l)  0.005± 0.005 
Cholesterol esters in chylomicrons and extremely large VLDL (mmol/l)  0.003± 0.003 
Free cholesterol in chylomicrons and extremely large VLDL (mmol/l) 0.002± 0.002 
Triglycerides in chylomicrons and extremely large VLDL (mmol/l) 0.020± 0.017 
Concentration of very large VLDL particles (nmol/l) 0.65± 0.65 
Total lipids in very large VLDL (mmol/l) 0.064± 0.0635 
Phospholipids in very large VLDL (mmol/l) 0.010± 0.011 
Total cholesterol in very large VLDL (mmol/l) 0.014± 0.013 
Cholesterol esters in very large VLDL (mmol/l) 0.007± 0.007 
Free cholesterol in very large VLDL (mmol/l) 0.007± 0.006 
Triglycerides in very large VLDL (mmol/l)  0.040± 0.040 
Concentration of large VLDL particles (nmol/l) 4.27± 3.47 
Total lipids in large VLDL (mmol/l)  0.247± 0.202 
Phospholipids in large VLDL (mmol/l) 0.045± 0.036 
Total cholesterol in large VLDL (mmol/l)  0.058± 0.048 
Cholesterol esters in large VLDL (mmol/l) 0.031± 0.024 
Free cholesterol in large VLDL (mmol/l) 0.027± 0.024 
Triglycerides in large VLDL (mmol/l) 0.145± 0.119 
Concentration of medium VLDL particles (nmol/l) 16.05± 8.73 
Total lipids in medium VLDL (mmol/l) 0.539± 0.290 
Phospholipids in medium VLDL (mmol/l) 0.110± 0.056 
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Total cholesterol in medium VLDL (mmol/l) 0.156± 0.077 
Cholesterol esters in medium VLDL (mmol/l) 0.093± 0.042 
Free cholesterol in medium VLDL (mmol/l) 0.064± 0.036 
Triglycerides in medium VLDL (mmol/l)  0.274± 0.162 
Concentration of small VLDL particles (nmol/l) 33.00± 10.27 
Total lipids in small VLDL (mmol/l)  0.658± 0.199 
Phospholipids in small VLDL (mmol/l)  0.151± 0.042 
Total cholesterol in small VLDL (mmol/l) 0.268± 0.074 
Cholesterol esters in small VLDL (mmol/l) 0.173± 0.049 
Free cholesterol in small VLDL (mmol/l) 0.095± 0.028 
Triglycerides in small VLDL (mmol/l)  0.239± 0.094 
Concentration of very small VLDL particles (nmol/l)  47.42± 10.17 
Total lipids in very small VLDL (mmol/l) 0.606± 0.129 
Phospholipids in very small VLDL (mmol/l)  0.169± 0.041 
Total cholesterol in very small VLDL (mmol/l)  0.315± 0.065 
Cholesterol esters in very small VLDL (mmol/l)  0.217± 0.043 
Free cholesterol in very small VLDL (mmol/l)  0.097± 0.024 
Triglycerides in very small VLDL (mmol/l)  0.122± 0.037 
IDL   
Concentration of IDL particles (nmol/l) 122.26± 29.33 
Total lipids in IDL (mmol/l)  1.235± 0.303 
Phospholipids in IDL (mmol/l)  0.324± 0.078 
Total cholesterol in IDL (mmol/l) 0.777± 0.206 
Cholesterol esters in IDL (mmol/l)  0.557± 0.146 
Free cholesterol in IDL (mmol/l) 0.220± 0.062 
LDL  
Concentration of large LDL particles (nmol/l)  192.03± 50.69 
Total lipids in large LDL (mmol/l)  1.364± 0.365 
Phospholipids in large LDL (mmol/l) 0.337± 0.077 
Total cholesterol in large LDL (mmol/l) 0.907± 0.270 
Cholesterol esters in large LDL (mmol/l)  0.647± 0.203 
Free cholesterol in large LDL (mmol/l) 0.260± 0.069 
Triglycerides in large LDL (mmol/l) 0.120± 0.033 
Concentration of medium LDL particles (nmol/l) 149.94± 43.17 
Total lipids in medium LDL (mmol/l) 0.762± 0.220 
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Phospholipids in medium LDL (mmol/l)  0.204± 0.044 
Total cholesterol in medium LDL (mmol/l)  0.502± 0.168 
Cholesterol esters in medium LDL (mmol/l) 0.357± 0.135 
Free cholesterol in medium LDL (mmol/l) 0.145± 0.033 
Triglycerides in medium LDL (mmol/l) 0.055± 0.018 
Concentration of small LDL particles (nmol/l)  173.68± 47.33 
Total lipids in small LDL (mmol/l) 0.488± 0.134 
Phospholipids in small LDL (mmol/l) 0.144± 0.028 
Total cholesterol in small LDL (mmol/l)  0.309± 0.101 
Cholesterol esters in small LDL (mmol/l)  0.221± 0.082 
Free cholesterol in small LDL (mmol/l) 0.088± 0.020 
Triglycerides in small LDL (mmol/l) 0.034± 0.011 
HDL  
Concentration of very large HDL particles (nmol/l) 519.47± 228.67 
Total lipids in very large HDL (mmol/l)  0.530± 0.234 
Phospholipids in very large HDL (mmol/l)  0.240± 0.125 
Total cholesterol in very large HDL (mmol/l)  0.272± 0.110 
Cholesterol esters in very large HDL (mmol/l) 0.199± 0.077 
Free cholesterol in very large HDL (mmol/l) 0.072± 0.033 
Triglycerides in very large HDL (mmol/l) 0.019± 0.008 
Concentration of large HDL particles (nmol/l) 1172.70± 566.13 
Total lipids in large HDL (mmol/l)  0.734± 0.362 
Phospholipids in large HDL (mmol/l) 0.360± 0.158 
Total cholesterol in large HDL (mmol/l)  0.340± 0.193 
Cholesterol esters in large HDL (mmol/l) 0.266± 0.146 
Free cholesterol in large HDL (mmol/l)  0.074± 0.047 
Triglycerides in large HDL (mmol/l) 0.035± 0.020 
Concentration of medium HDL particles (nmol/l)  1912.49± 412.82 
Total lipids in medium HDL (mmol/l) 0.806± 0.179 
Phospholipids in medium HDL (mmol/l)  0.392± 0.078 
Total cholesterol in medium HDL (mmol/l) 0.369± 0.100 
Cholesterol esters in medium HDL (mmol/l)  0.295± 0.079 
Free cholesterol in medium HDL (mmol/l)  0.073± 0.022 
Triglycerides in medium HDL (mmol/l) 0.046± 0.015 
Concentration of small HDL particles (nmol/l)  4846.44± 566.78 
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Total lipids in small HDL (mmol/l)  1.074± 0.127 
Phospholipids in small HDL (mmol/l) 0.585± 0.078 
Total cholesterol in small HDL (mmol/l)  0.434± 0.072 
Cholesterol esters in small HDL (mmol/l)  0.321± 0.064 
Free cholesterol in small HDL (mmol/l)  0.112± 0.017 
Triglycerides in small HDL (mmol/l)  0.055± 0.015 
Mean diameter of VLDL, LDL and HDL   
Mean diameter for VLDL particles (nm)  36.14± 1.23 
Mean diameter for LDL particles (nm) 23.67± 0.14 
Mean diameter for HDL particles (nm) 9.99± 0.26 
Mean ± SD is reported for all of variables. 
 
Table 8 shows the dietary intakes of nutrients among participants. According to the table, around 
18% of energy was derived from protein, 50% of energy was supplied by carbohydrate, and 31% 
percent of energy was derived from total fat. Participants approximately obtained 12% of energy 
from SFA, 9% of energy from MUFA and 5% of energy from PUFA. In average, they consumed 
0.12 g/day EPA and 0.28 g/day DHA, as well.  
 
Table 8. Dietary intake of participants.  
Dietary intake of participants  
n= 554 
  Mean ± SD 
Energy (kcal/d) 1568± 372 
Protein (E%) 17.6± 3.1 
Carbohydrates (E%) 49.1± 5.8 
Fat (E%) 31.1± 5.6 
Saturated fatty acids (E%) 12.2± 3.1 
Monounsaturated fatty acids (E%) 9.8± 2.4 
Polyunsaturated fatty acids (E%) 5.1± 1.4 
Palmitic acid C16 (g/d) 9.91± 3.95 
Stearic acid C18 (g/d) 3.85± 1.63 
Linoleic acid C18:2 (g/d) 5.88± 2.34 
Linolenic acid C18:3 (g/d) 1.45± 0.78 
Arachidonic acid C20:4 (g/d) 0.11± 0.08 
Eicosapentaenoic acid C20:5 (g/d)  0.12± 0.14 
Docosahexaenoic acid C22:6 (g/d) 0.28± 0.33 
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5.2 Association between Dietary Fat and Lipoprotein Subclasses 
The results of correlation analyses are reported in Table 9. Besides to the fatty acids reported in 
the table, arachidonic acid, palmitic acid, linoleic acid and linolenic acid were entered in the 
correlation analysis, but they did not have significant correlation with lipoprotein subclasses. 
Based on the results of these analyses, intake of PUFA had significant positive correlations with 
triglycerides in medium and small VLDL, concentration of small VLDL and mean diameter of 
VLDL. In addition, smaller mean diameter of LDL significantly related to higher intake of 
MUFA, PUFA and total fat. Furthermore, total fat intake had positive correlations with free 
cholesterol in medium and small LDL, concentration of small LDL, total lipid and phospholipid 
in small LDL. Higher intake of EPA significantly correlated with higher total cholesterol, 
cholesterol ester and free cholesterol in very small VLDL while, intake of DHA had positive 
correlation only with total cholesterol and cholesterol ester in very small VLDL. In addition, 
EPA and DHA negatively correlated with triglycerides in chylomicron and extremely large 
VLDL. EPA had negative correlation with the mean diameter of VLDL, as well. 
SFA (E%) had positive correlations with total cholesterol in very small VLDL, medium and 
small HDL, large, medium and small LDL and IDL. In addition, it positively associated with 
higher concentrations of IDL, small, medium and large LDL particles. Higher intake of SFA also 
significantly related with higher phospholipid in IDL, large LDL, medium LDL and small LDL. 
It had significant positive correlations with cholesterol ester in IDL, large, medium and small 
LDL, very small VLDL and small HDL. Moreover, total lipid and free cholesterol in IDL, large, 
medium and small LDL positively correlated with intake of SFA.   
Furthermore, intake of protein had negative correlations with lots of the lipoprotein subclasses, 
including total lipid and total cholesterol in IDL, total cholesterol and cholesterol ester in large 
LDL, phospholipid, total cholesterol and cholesterol ester in medium LDL, total cholesterol and 
cholesterol ester in small LDL, free cholesterol in very large HDL and total cholesterol in 
medium HDL. In addition, further correlation analysis revealed that the intake of protein had 
negative correlations with intake of SFA and total fat.  
Moreover, the intake of EPA plus DHA had positive correlations with cholesterol ester and total 
cholesterol in very small VLDL (p = 0.011 and 0.020, respectively). Triglycerides in 
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chylomicron and extremely large VLDL had negative correlation with intake of EPA plus DHA 
as well (p= 0.041). In addition, further analysis revealed that there was not any significant 
difference in distribution of VLDL and HDL subclasses among the three categories of fish intake 
(no use or once per month, 0.5-.1 times per week and two or more times per week). 
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Table 9. Correlation coefficient from Pearson and Spearman correlation analysis. 
  Energy 
(kcal)  
Protein 
(E%) 
Fat 
(E%) 
MUFA 
(E%) 
Carboh
ydrates 
(E%) 
PUFA 
(E%) 
SFA 
(E%) 
Eicosa
pentae
noic 
acid 
(g/d) 
Docosa
hexaen
oic 
acid 
(g/d) 
VLDL           
Concentration of chylomicron and extremely large VLDL 
(mol/L) 
0.02 -0.028 0.043 0.058 0.002 0.036 0.048 -0.078 -0.081 
Total lipid in chylomicron and extremely large VLDL (mmol/L) 0.022 -0.028 0.043 0.057 0.003 0.034 0.048 -0.076 -0.08 
Phospholipid in chylomicron and extremely large VLDL 
(mmol/L) 
0.023 -0.014 0.036 0.066 0.002 0.051 0.029 -0.067 -0.07 
Total cholesterol in chylomicron and extremely large VLDL 
(mmol/L) 
0.049 -0.034 0.044 0.044 -0.001 0.018 0.06 -0.047 -0.057 
Cholestrolester in chylomicron and extremely large VLDL 
(mmol/L) 
0.065 -0.051 0.05 0.037 0.000 0.011 0.071 -0.038 -0.048 
Free cholesterol in chylomicron and extremely large VLDL 
(mmol/L) 
0.025 -0.01 0.032 0.05 0.002 0.028 0.037 -0.068 -0.076 
Triglycerides in chylomicron and extremely large VLDL 
(mmol/L) 
0.015 -0.029 0.045 0.061 0.001 0.037 0.048 -.087* -.089* 
Concentration of very large VLDL (mol/L) 0.017 0.002 0.027 0.056 0.003 0.047 0.021 -0.075 -0.076 
Total lipid in very large VLDL (mmol/L) 0.019 -0.001 0.029 0.056 0.002 0.046 0.025 -0.074 -0.076 
Phospholipid in very large VLDL (mmol/L) 0.025 -0.011 0.038 0.057 0 0.04 0.037 -0.075 -0.08 
Total cholesterol in very large VLDL (mmol/L) 0.041 -0.023 0.044 0.051 -0.006 0.028 0.053 -0.054 -0.062 
Cholesterolester in very large VLDL (mmol/L) 0.042 -0.023 0.038 0.047 -0.003 0.029 0.047 -0.049 -0.055 
Free cholesterol in very large VLDL (mmol/L) 0.036 -0.025 0.05 0.054 -0.008 0.029 0.056 -0.059 -0.068 
Triglycerides in very large VLDL (mmol/L) 0.009 0.009 0.02 0.056 0.005 0.051 0.011 -0.08 -0.078 
Concentration of large VLDL (mol/L) 0.01 0.015 0.016 0.064 0.003 0.077 -0.004 -0.063 -0.059 
Total lipid in large VLDL (mmol/L) 0.011 0.015 0.016 0.063 0.003 0.075 -0.003 -0.062 -0.059 
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  Energy 
(kcal)  
Protein 
(E%) 
Fat 
(E%) 
MUFA 
(E%) 
Carboh
ydrates 
(E%) 
PUFA 
(E%) 
SFA 
(E%) 
Eicosa
pentae
noic 
acid 
(g/d) 
Docosa
hexaen
oic 
acid 
(g/d) 
Phospholipid in large VLDL (mmol/L) 0.013 0.009 0.017 0.062 0.007 0.071 0.001 -0.063 -0.062 
Total cholesterol in large VLDL (mmol/L) 0.029 0.004 0.015 0.054 0.007 0.061 0.006 -0.051 -0.051 
Cholesterolester in large VLDL (mmol/L) 0.038 -0.01 0.015 0.047 0.008 0.06 0.008 -0.04 -0.04 
Free cholesterol in large VLDL (mmol/L) 0.02 0.009 0.017 0.058 0.007 0.061 0.004 -0.063 -0.064 
Triglycerides in large VLDL (mmol/L) 0.004 0.018 0.015 0.066 0.003 0.081 -0.008 -0.067 -0.061 
Concentration of medium VLDL  (mol/L) -0.02 0.004 -0.001 0.062 0.023 0.08 -0.007 -0.047 -0.046 
Total lipid in medium VLDL  (mmol/L) -0.017 0.002 -0.001 0.06 0.023 0.078 -0.006 -0.047 -0.046 
Phospholipid in medium VLDL (mmol/L) -0.013 -0.002 0.001 0.059 0.022 0.075 -0.003 -0.047 -0.048 
Total cholesterol in medium VLDL (mmol/L) 0.016 -0.017 0.01 0.047 0.017 0.059 0.011 -0.035 -0.041 
Cholesterolester in medium VLDL (mmol/L) 0.059 -0.023 0.018 0.031 0.014 0.036 0.029 -0.027 -0.037 
Free cholesterol in medium VLDL (mmol/L) 0.019 0.014 0.01 0.061 0.009 0.08 -0.012 -0.049 -0.05 
Triglycerides in medium VLDL (mmol/L) -0.033 0.012 -0.005 0.067 0.025 .086* -0.017 -0.052 -0.047 
Concentration of small VLDL (mol/L) -0.005 -0.006 0.001 0.06 0.026 .086* -0.012 -0.005 -0.011 
Total lipid in small VLDL (mmol/L) 0 -0.011 0.004 0.059 0.024 0.083 -0.007 0 -0.007 
Phospholipid in small VLDL (mmol/L) 0.007 -0.005 -0.004 0.058 0.024 0.083 -0.023 0.01 0.005 
Total cholesterol in small VLDL (mmol/L) 0.032 -0.05 0.032 0.046 0.012 0.054 0.045 0.036 0.022 
Cholesterolester in small VLDL  (mmol/L) 0.046 -0.069 0.047 0.038 0.005 0.037 0.075 0.05 0.034 
Free cholesterol in small VLDL (mmol/L) 0.006 -0.014 0 0.053 0.027 0.078 -0.009 0.011 0.004 
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  Energy 
(kcal)  
Protein 
(E%) 
Fat 
(E%) 
MUFA 
(E%) 
Carboh
ydrates 
(E%) 
PUFA 
(E%) 
SFA 
(E%) 
Eicosa
pentae
noic 
acid 
(g/d) 
Docosa
hexaen
oic 
acid 
(g/d) 
Triglyceride in small VLDL (mmol/L) -0.027 0.015 -0.018 0.059 0.038 .094* -0.042 -0.029 -0.03 
Concentration of very small VLDL (mol/L) 0.038 -0.03 0.029 0.034 -0.008 0.033 0.035 0.056 0.047 
Total lipid in very small VLDL (mmol/L) 0.043 -0.034 0.034 0.032 -0.012 0.028 0.045 0.063 0.053 
Phospholipid in very small VLDL (mmol/L) 0.035 -0.054 0.033 0.024 -0.005 0.02 0.052 0.05 0.038 
Total cholesterol in very small VLDL (mmol/L) 0.072 -0.045 0.055 0.023 -0.033 0.007 .085* .107* .095* 
Cholesterolester very small VLDL (mmol/L) 0.066 -0.029 0.058 0.02 -0.062 -0.034 .095* .117** .103* 
Free cholesterol in very small VLDL (mmol/L) 0.045 -0.031 0.04 0.026 -0.017 0.029 0.058 .088* 0.077 
Triglycerides in very small VLDL (mmol/L) -0.014 0.014 -0.033 0.033 0.043 0.067 -0.057 0.004 -0.002 
IDL          
Concentration of IDL (mol/L) 0.039 -.101* 0.057 0.013 -0.006 -0.024 .104* 0.013 -0.003 
Total lipid in IDL (mmol/L) 0.024 -.089* 0.053 0.009 -0.007 -0.069 .109* 0.017 0 
Phospholipid in IDL (mmol/L) 0.039 -.111** 0.061 0.011 -0.005 -0.029 .113** 0.008 -0.009 
Total cholesterol in IDL (mmol/L) 0.029 -.094* 0.068 0.012 -0.021 -0.067 .124** 0.026 0.009 
Cholesterolester in IDL (mmol/L) 0.051 -.110** 0.061 0.008 -0.009 -0.033 .127** 0.023 0.007 
Free cholesterol in IDL (mmol/L) 0.016 -0.078 0.055 0.007 -0.014 -0.072 .113** 0.027 0.011 
Triglycerides in IDL (mmol/L) 0.004 -0.001 -0.044 0.005 0.041 -0.023 -0.026 0.021 0.014 
LDL          
Concentration of large LDL (mol/L) 0.028 -.113** 0.072 0.029 -0.012 -0.013 .115** 0 -0.018 
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  Energy 
(kcal)  
Protein 
(E%) 
Fat 
(E%) 
MUFA 
(E%) 
Carboh
ydrates 
(E%) 
PUFA 
(E%) 
SFA 
(E%) 
Eicosa
pentae
noic 
acid 
(g/d) 
Docosa
hexaen
oic 
acid 
(g/d) 
Total lipid in large LDL (mmol/L) 0.03 -.114** 0.073 0.028 -0.013 -0.014 .117** 0.002 -0.016 
Phospholipid in large LDL (mmol/L) 0.036 -.113** 0.075 0.03 -0.019 -0.014 .124** 0.002 -0.014 
Total cholesterol in large LDL (mmol/L) 0.024 -.102* 0.073 0.024 -0.015 -0.053 .124** 0.007 -0.011 
Cholesterolester in large LDL (mmol/L) 0.025 -.103* 0.074 0.028 -0.015 -0.045 .123** 0.005 -0.012 
Free cholesterol in large LDL (mmol/L) 0.034 -.115** 0.072 0.015 -0.011 -0.024 .129** 0.008 -0.009 
Triglycerides in large LDL (mmol/L) -0.008 -0.058 0.017 0.016 0.017 -0.008 0.011 -0.001 -0.012 
Concentration of medium LDL (mol/L) 0.016 -.116** 0.08 0.045 -0.016 0.002 .111** -0.006 -0.025 
Total lipid in medium LDL (mmol/L) 0.018 -.116** 0.081 0.044 -0.017 0.002 .114** -0.005 -0.023 
Phospholipid in medium LDL (mmol/L) 0.034 -.112** .092* 0.049 -0.026 -0.034 .130** -0.005 -0.018 
Total cholesterol in medium LDL (mmol/L) 0.014 -.101* 0.071 0.032 -0.011 -0.039 .115** 0.001 -0.018 
Cholesterolester in medium LDL (mmol/L) 0.011 -.099* 0.068 0.034 -0.009 -0.033 .110** 0 -0.019 
Free cholesterol in medium LDL (mmol/L) 0.029 -.118** .097* 0.041 -0.032 -0.008 .136** 0.004 -0.012 
Triglycerides in medium LDL (mmol/L) -0.012 -0.055 -0.009 0.012 0.044 -0.045 0.017 -0.026 -0.037 
Concentration of small LDL (mol/L) 0.013 -.119** .087* 0.058 -0.023 0.012 .111** -0.002 -0.017 
Total lipid in small LDL (mmol/L) 0.015 -.119** .089* 0.058 -0.025 0.011 .115** 0 -0.015 
Phospholipid in small LDL (mmol/L) 0.021 -.117** .104* 0.073 -0.046 0.017 .126** -0.005 -0.011 
Total cholesterol in small LDL (mmol/L) 0.008 -.103* 0.075 0.037 -0.014 -0.033 .116** 0.004 -0.012 
Cholesterolester in small LDL (mmol/L) 0.004 -.102* 0.07 0.036 -0.01 -0.03 .111** 0.002 -0.015 
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  Energy 
(kcal)  
Protein 
(E%) 
Fat 
(E%) 
MUFA 
(E%) 
Carboh
ydrates 
(E%) 
PUFA 
(E%) 
SFA 
(E%) 
Eicosa
pentae
noic 
acid 
(g/d) 
Docosa
hexaen
oic 
acid 
(g/d) 
Free cholesterol in small LDL (mmol/L) 0.029 -.117** .108* 0.059 -0.044 0.009 .131** 0.009 -0.003 
Triglycerides in small LDL (mmol/L) -0.023 -0.074 0.01 0.04 0.037 0.019 0.005 -0.046 -0.06 
HDL          
Concentration of very large HDL (mol/L) -0.014 -0.06 0.023 -0.021 0.009 -0.033 0.028 0.032 0.044 
Total lipid in very large HDL (mmol/L) -0.013 -0.063 0.026 -0.019 0.007 -0.033 0.032 0.033 0.045 
Phospholipid in very large HDL (mmol/L) -0.017 -0.046 0.006 -0.028 0.017 -0.03 0.009 0.03 0.044 
Total cholesterol in very large HDL (mmol/L) -0.01 -0.08 0.055 -0.002 -0.014 -0.031 0.062 0.036 0.047 
Cholesterolester in very large HDL (mmol/L) -0.013 -0.079 0.055 0.001 -0.015 -0.027 0.06 0.036 0.047 
Free cholesterol in very large HDL (mmol/L) -0.005 -.085* 0.06 -0.003 -0.017 -0.042 0.07 0.032 0.047 
Triglycerides in very large HDL (mmol/L) 0.01 -0.056 0.009 -0.027 0.04 -0.059 0.036 -0.057 -0.076 
Concentration of large HDL (mol/L) -0.02 -0.01 -0.012 -0.036 0.015 -0.029 -0.007 0.024 0.032 
Total lipid in large HDL (mmol/L) 0.021 -0.008 -0.001 -0.03 -0.014 -0.03 -0.006 0.026 0.033 
Phospholipid in large HDL (mmol/L) 0.026 -0.016 -0.001 -0.026 -0.015 -0.031 -0.004 0.025 0.032 
Total cholesterol in large HDL (mmol/L) 0.021 -0.007 0.004 -0.026 -0.017 -0.025 -0.009 0.031 0.04 
Cholesterolester in large HDL (mmol/L) 0.022 -0.006 0.004 -0.026 -0.018 -0.026 -0.008 0.03 0.039 
Free cholesterol in large HDL (mmol/L) -0.019 -0.01 -0.011 -0.033 0.013 -0.023 -0.009 0.036 0.045 
Triglycerides in large HDL (mmol/L) 0.012 0.001 -0.039 -0.07 0.048 -0.056 0.001 -0.009 -0.017 
Concentration of medium HDL (mol/L) 0.029 0.001 0.012 0.041 -0.028 0.026 0.002 0.007 0.024 
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  Energy 
(kcal)  
Protein 
(E%) 
Fat 
(E%) 
MUFA 
(E%) 
Carboh
ydrates 
(E%) 
PUFA 
(E%) 
SFA 
(E%) 
Eicosa
pentae
noic 
acid 
(g/d) 
Docosa
hexaen
oic 
acid 
(g/d) 
Total lipid in medium HDL (mmol/L) 0.028 0.001 0.013 0.041 -0.03 0.026 0.002 0.012 0.029 
Phospholipid in medium HDL (mmol/L) 0.027 -0.016 0.013 0.04 -0.023 0.017 0.004 0.007 0.023 
Total cholesterol in medium HDL (mmol/L) 0.014 -.101* 0.071 0.032 -0.011 -0.039 .115** 0.001 -0.018 
Free cholesterol in medium HDL (mmol/L) 0.024 0 0.004 0.029 -0.026 0.017 -0.003 0.033 0.048 
Cholesterolester in medium HDL (mmol/L) 0.021 0.022 0.015 0.039 -0.044 0.033 -0.004 0.024 0.042 
Triglycerides in medium HDL (mmol/L) 0.054 0.003 -0.039 -0.005 0.039 0.004 -0.025 -0.041 -0.05 
Concentration of small HDL (mol/L) 0.019 -0.019 0.042 0.068 -0.035 0.024 0.037 -0.013 -0.005 
Total lipid in small HDL (mmol/L) 0.019 -0.022 0.046 0.07 -0.038 0.024 0.042 -0.009 0 
Phospholipid in small HDL (mmol/L) 0.033 0.033 -0.014 0.026 -0.045 0 -0.027 -0.022 -0.006 
Total cholesterol in small HDL (mmol/L) 0.006 -0.072 0.083 0.061 -0.031 -0.002 .109* -0.003 -0.006 
Cholesterolester in small HDL (mmol/L) 0.001 -0.077 0.079 0.058 -0.024 -0.001 .105* -0.002 -0.011 
Free cholesterol in small HDL (mmol/L) 0.02 0.016 0.026 0.038 -0.043 0.015 0.018 -0.013 -0.002 
Triglycerides in small HDL (mmol/L) -0.009 -0.014 -0.042 -0.014 0.063 -0.011 -0.029 -0.065 -0.082 
Mean diameter of VLDL, LDL and HDL          
Mean diameter of VLDL (nm) 0.005 0.013 0.01 0.055 0.014 .087* -0.017 -.086* -0.081 
Mean diameter of LDL (nm) 0.028 0.062 -.112** -.119** 0.056 -.097* -0.08 0.032 0.033 
Mean diameter of HDL (nm) -0.015 -0.028 -0.004 -0.037 0.015 -0.034 0.004 0.03 0.043 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
MUFA= monounsaturated fatty acids, PUFA = polyunsaturated fatty acids and SFA= saturated fatty acids. 
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The Pearson correlation coefficient is reported for correlations between normally distributed variables. 
The Spearman correlation coefficient is reported for correlations between variables that either one of them or both are not normally distributed. 
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Although total fat (E %), PUFA (E %), MUFA (E %), EPA and DHA had some correlations with 
different subclasses of lipoprotein, most of the significant correlations were observed between 
SFA (E %) and lipoprotein subclasses. In addition, subclasses of VLDL, LDL and IDL had the 
higher amount of significant correlations with dietary fatty acids in comparison to subclasses of 
HDL. Therefore, tertiles of SFA intake (E%) were made to evaluate the relation of SFA and 
subclasses of VLDL, LDL and IDL. The result of this ANCOVA test with adjustment for 
physical activity, intake of lipid lowering drugs, smoking, age and BMI is shown in Table 10. 
After these adjustments, two significant and not linear relations between intake of SFA (E%) and 
subclasses of LDL and VLDL were found. The higher intake of SFA significantly associated 
with the smaller size of LDL particles (p=0.04) (Figure 1). Post hoc analysis showed that the 
difference in the mean diameter of LDL is significant between the middle and highest tertiles 
categories of SFA (P= 0.035).  In addition, higher intake of SFA significantly related to the 
lower amount of triglyceride in small VLDL (p=0.046). The differences between the mean of 
triglycerides in small VLDL was significant between lowest and middle tertiles of SFA (E%) (P= 
0.039). Higher intake of SFA tended to be in significant relation with higher amount of 
phospholipid in small LDL, as well (p=0.06).  
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Table 10. Concentration of lipoprotein particles in tertiles of saturated fatty acid intake (E%). 
  First tertile (3.6- 
10.8) 
Second tertile 
(10.8-13.3)  
Third tertile (13.3-
24.9)  
P 
trend 
N 185 185 185 - 
Total lipid in chylomicron and extremely large VLDL (mmol/L) 0.029± 0.027 0.026± 0.019 0.030± 0.028 0.372 
Phospholipid in chylomicron and extremely large VLDL (mmol/L) 0.003±  0.003 0.003± 0.002 0.003± 0.003 0.309 
Total cholesterol in chylomicron and extremely large VLDL (mmol/L) 0.005± 0.005 0.005± 0.004 0.006± 0.005 0.359 
Cholesterol ester in chylomicron and extremely large VLDL (mmol/L) 0.003± 0.003 0.003± 0.002 0.003± 0.003 0.485 
Free cholesterol in chylomicron and extremely large VLDL (mmol/L) 0.002± 0.002 0.002± 0.002 0.002± 0.002 0.249 
Concentration of very large VLDL (nmol//l) 0.688± 0.727 0.565± 0.498 0.702± 0.688 0.564 
Total lipid in very large VLDL (mmol/L) 0.068± 0.071 0.056± 0.049 0.069± 0.067 0.550 
Phospholipid in very large VLDL (mmol/L) 0.011± 0.012 0.009± 0.008 0.011± 0.011 0.585 
Total cholesterol in very large VLDL (mmol/L) 0.015± 0.015 0.013± 0.010 0.015± 0.014 0.528 
Cholesterol ester in very large VLDL (mmol/L) 0.008± 0.008 0.007± 0.005 0.008± 0.007 0.685 
Free cholesterol in very large VLDL (mmol/L) 0.007± 0.007 0.006± 0.005 0.007± 0.007 0.442 
Triglyceride in very large VLDL (mmol/L) 0.042± 0.045 0.034± 0.031 0.043± 0.043 0.596 
Concentration of large VLDL (nmol/L) 4.527± 3.875 3.736± 2.649 4.512± 3.671 0.467 
Total lipid in large VLDL (mmol/L) 0.262± 0.225 0.217± 0.154 0.262± 0.214 0.468 
Phospholipid in large VLDL (mmol/L) 0.047± 0.41 0.39± 0.028 0.047± 0.038 0.420 
Total cholesterol in large VLDL (mmol/L) 0.061± 0.053 0.051± 0.037 0.061± 0.052 0.555 
Cholesterol ester in large VLDL (mmol/L) 0.032± 0.026 0.028± 0.019 0.033± 0.026 0.755 
Free cholesterol in large VLDL (mmol/L) 0.028± 0.027 0.023± 0.019 0.028± 0.026 0.511 
Triglyceride in large VLDL (mmol/L) 0.154± 0.133 0.126± 0.091 0.153± 0.125 0.467 
Phospholipid in medium VLDL (mmol/L) 0.114± 0.061 0.100± 0.043 0.114± 0.062 0.165 
Total cholesterol in medium VLDL (mmol/L) 0.160± 0.085 0.145± 0.062 0.162± 0.085 0.224 
Cholesterol ester in medium VLDL (mmol/L) 0.094± 0.046 0.088± 0.036 0.095± 0.046 0.397 
Free cholesterol in medium VLDL (mmol/L) 0.067± 0.040 0.057± 0.028 0.066± 0.041 0.138 
Phospholipid in small VLDL (mmol/L) 0.155± 0.042 0.144± 0.034 0.153± 0.049 0.099 
Triglyceride in small VLDL (mmol/L) 0.250± 0.097 0.220± 0.071 0.246± 0.113 0.046 
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Concentration of very small VLDL (nmol/L) 47.635± 10.287 46.317± 8.953 48.054± 11.394 0.282 
Total lipid in very small VLDL (mmol/L) 0.607± 0.132 0.594± 0.115 0.614± 0.143 0.377 
Free cholesterol in very small VLDL (mmol/L) 0.097± 0.024 0.095± 0.021 0.099± 0.026 0.554 
Triglyceride in large LDL (mmol/L) 0.121± 0.033 0.115± 0.027 0.122± 0.036 0.146 
Triglyceride in medium LDL (mmol/L) 0.056± 0.017 0.053± 0.014 0.057± 0.019 0.141 
Concentration of small LDL (nmol/L) 170.823± 46.934 170.440± 43.127 181.791± 52.546 0.182 
Total lipid in small LDL (mmol/L) 0.479± 0.132 0.479± 0.122 0.511± 0.149 0.189 
Phospholipid in small LDL (mmol/L) 0.143± 0.028 0.142± 0.025 0.150± 0.030 0.066 
The Multivariate ANOVA model was adjusted for BMI, age, physical activity, lipid lowering drugs and smoking. 
Unadjusted mean ± SD was reported for all of the variables.  
Log transformed variables were used for analysis.  
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6. DISCUSSION  
 
This is the first study that showed the significant non-linear correlation between the intake of 
SFA and subclasses of LDL and VLDL defined by the NMR method. We found that the mean 
diameter of LDL is significantly higher in the middle tertile categories of SFA in comparison to 
the highest tertile of SFA. In addition, lowest tertile of SFA intake had significantly higher mean 
triglycerides in small VLDL than the middle tertile of SFA. It should be noted, that the 
mentioned non-linear and negative correlation was found after adjustment for BMI, age, physical 
activity, lipid lowering drugs and smoking in postmenopausal women. 
 
6.1 Intake of SFA and Mean Size of LDL Particles  
Previous Studies 
The result of the present study is consistent with an interventional study involving ten mildly 
hypercholesterolemic men. In this study, participants were fed different kinds of hamburgers (5 
patties per week) in a crossover design. The intervention started with the consumption of 
hamburger rich in SFA (MUFA/ SFA= 0.95) for 5 weeks, then followed by usual diet for 3 
weeks. Afterwards, participants consumed hamburger rich in MUFA (MUFA/ SFA= 1.31) for 
another 5 weeks. It should be mentioned that the 114 g hamburger patties which were made from 
beef were provided for participants. The result of mentioned study showed that the intake of 
hamburger rich in SFA decreased the LDL particle diameter. In addition, this study found that 
the decline of LDL diameter remained even after 3 week washout period or after intake of 
hamburger rich in MUFA (Adams et al. 2010). Furthermore, in another interventional study, 
Smith and his colleague reported that the intake of hamburger rich in SFA (MUFA/ SFA= 0.83-
0.96) increased the apo B/ LDL cholesterol (Smith et al 2002). Since according to the result of 
present study and another study conducted by Hayashi and his colleagues, the apoB negatively 
correlated with the mean size of LDL (Hayashi et al. 2006), higher apoB/ LDL might be related 
to decreased size and increased density of LDL.  
 
Moreover, in an interventional study low carbohydrate, high SFA diet (15% of energy from 
SFA) decreased the mean diameter of LDL as compared to low carbohydrate, low SFA diet (8% 
of energy from SFA), but this reduction was not significant. The main source of SFA in this 
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study was dairy products (Mangravite et al. 2011). It should be noted that different kinds of SFA 
might have various effects on subclasses of LDL. For example, while it is found that intake of 
total SFA increased the LDL cholesterol, the intake of stearic acid (one of the main sources of 
stearic acid is dairy products) decreased the LDL cholesterol in a dose- response relation (Hunter 
et al. 2010). In addition, a cross-sectional study found that SFA derived from milk products had 
negative correlation with concentration of small LDL particles (Sjogren et al. 2004). Therefore, 
not finding a significant relation in this study might be due to not having control over the sources 
of SFA.  
 
Based on a review which was done by Hunter and his colleagues in most of the studies that 
aimed to find the effects of SFA intake on risk of CHD, a positive correlation between intake of 
SFA and risk of CHD or other coronary events was found (Hunter et al. 2010). Numerous studies 
reported that the predominance of small and dense LDL is related to two or three times increased 
risk of CVD (Krauss 2001, Gerber & Berneis 2012). Therefore, the intake of SFA might increase 
the risk of CHD through decreasing the mean diameter of LDL.  
 
On the contrary, in an interventional study Dreon and his colleagues reported that intake of SFA 
increased the mean diameter of LDL particles (Dreon et al. 1998). In this study, healthy men 
consumed either a high fat (46% of energy from fat, 18% of energy from SFA, and 39 % of 
energy from carbohydrate) or a low fat diet (24% of energy from fat, 6% of energy from SFA, 
and 59% of energy from carbohydrate) in a crossover design. Although the intake of MUFA and 
PUFA were similar in both diets, the intake of carbohydrate differed greatly and carbohydrate 
was replaced with SFA in the low fat diet. It is reported that dietary carbohydrate did not have a 
linear correlation with plasma lipoprotein, but it might have a non-linear correlation with 
lipoprotein particles. In addition, based on a result of a review article, recent studies 
demonstrated that the high intake of carbohydrate decreased the size of LDL (Gerber & Bernis 
2012). Therefore, lower consumption of carbohydrate in this study might be the reason of 
increasing the mean size of LDL, not higher intake of SFA.  
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Probable Mechanism 
Some probable mechanisms for the relation between intake of SFA and size of LDL particles can 
be discussed, but further studies are needed to find the mechanism. ApoCIII exist on the surface 
of VLDL, LDL and HDL particles. This apolipoprotein has a strong impact on the metabolism of 
VLDL, LDL and HDL particles. It is reported that apoCIII significantly increased the level of 
small LDL and decreased the mean diameter of LDL particles independent of TG level. This 
effect might happen due to increasing the secretion, and decreasing the catabolism of TG- rich 
lipoproteins. ApoCIII can be the reason of the mentioned changes through inhibiting the 
lipoprotein lipase activity and decreasing uptake of apoCIII enriched VLDL that follow with 
higher circulation of VLDL and greater exchange of VLDL triglyceride for the cholesterol esters 
of LDL and HDL. Consequently, produced LDL is denser and smaller (Shin & Krauss 2010). 
However, a kinetic study showed that apoCIII increased the production of dense LDL by 
accelerating the action of hepatic lipase and not inhibiting lipoprotein lipase activity. In addition, 
it has been found that apoCIII decreased the liver clearance of all lipoproteins enriched in apoB 
that lead to increased formation of LDL (Mendivil et al. 2010). Although there is not consistency 
about the impact of apoCIII on lipoprotein lipase activity, both theories reached to the same 
result about the effect of apoCIII on the formation of small and dense LDL.  
 
On the other hand, an interventional study showed that diet rich in SFA (15% of energy from 
SFA, 15% of energy from MUFA) significantly increased the amount of apoCIII in LDL by 
33.5% in comparison to diet low in SFA and rich in MUFA (8% of energy from SFA and 21% of 
energy from MUFA). It should be mentioned that other macronutrients were kept constant in this 
study, the intake of carbohydrate was moderate and the changes were independent of the TG 
level (Faghihnia et al. 2012). In addition, another interventional study that used two different 
diets, including low SFA diet (8% of energy from SFA) and high SFA diet (15% energy from 
SFA with replacement of SFA by MUFA) showed that lower intake of SFA decreased the 
activity of hepatic lipase (Mangravite et al. 2011). Therefore, SFA might increase the formation 
of small LDL or decrease the mean diameter of LDL by increasing the concentration of apoCIII 
and decreasing the hepatic lipase activity.  
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Furthermore, there were several negative correlations between protein intake and lipid content of 
LDL, IDL and HDL particles. In addition, we found that the intake of protein had negative 
correlation with intake of SFA and total fat (p< 0.001). Therefore, lower concentration of the 
lipid component of LDL, HDL and IDL subclasses might be due to lower intake of SFA and total 
fat and not higher intake of protein. However, based on the result of a review, the effect of 
protein on lipid profile of plasma remained unclear (El Khoury & Anderson 2013). Therefore, 
further studies are needed to investigate the relation between intake of protein and lipid profile of 
plasma. 
 
6.2 Intake of SFA and Concentration of TG in Small VLDL 
To our knowledge in this study the negative correlation between SFA intake and concentration of 
triglycerides in small VLDL was found for the first time. Therefore, more studies are needed to 
confirm the result and investigate the potential mechanism of this association.  
 
6.3 Intake of Unsaturated Fatty Acids and Lipoprotein Subclasses 
Although there is lots of evidence about the effect of unsaturated fatty acids, especially PUFA on 
lipoprotein subclasses (Almario 2001, Goyens & Mensink 2005, Bos et al. 2007, Neff et al. 
2011, Perez-Martinez et al. 2011, Annuzzi et al. 2012, Parlesak et al. 2014), we only found a few 
relations between unsaturated fatty acids and lipoprotein subclasses. In addition, in contrast to 
the several studies that found the significant relations between intake of fish and lipoprotein 
subclasses mainly HDL (Li et al. 2004, Erkkila et al. 2014, Lankinen et al. 2014), we did not find 
any significant differences in distribution of VLDL and HDL subclasses through categories of 
fish intake. This contrast might be due to some factors. First, intakes of fish and unsaturated fatty 
acids among participants were low in the current study as compared to other studies. Second, 
variations in intakes of fish and unsaturated fatty acids were not large enough to find an 
association.  
 
6.4 Strengths and Weaknesses 
Using the large population is one strength of this study, but the non-response rate of 36.5% 
decreased the benefit of that. Since the 750 participants were randomly selected from 3432 
volunteered women, the sample is representative of cohort population and the result of study is 
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generalizable to the population. Moreover, availability of diet records and lipoprotein subclasses 
defined by NMR is another strength of this study. However, micro and macro nutrients are used 
instead of food so this study ignored the special characteristics of food, which might be the 
reason of found correlations. Using the cross-sectional design that cannot find the causal relation 
is another weakness of this study.   
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7. CONCLUSION 
Our result suggests that the higher intake of SFA might be related to the unfavorable size of LDL 
particles which has been related to increased risk of heart diseases. In addition, we found that 
higher intake of SFA correlated with lower amount of triglyceride in small VLDL for the first 
time. This result supports the need for further longitudinal and interventional studies to elucidate 
the mechanism of the relation between SFA intake and lipoprotein subclasses and to clarify the 
clinical meaning of this associations.  
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